ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,1,Migraine,Migraine headaches,Headaches,Nerv,N
3,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4,1,Headache,Headaches NEC,Headaches,Nerv,N
5,1,Lip and/or oral cavity cancer,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
6,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
8,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
8,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
9,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
9,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
10,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
12,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
13,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
16,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
16,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
17,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
18,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
20,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
21,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
21,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
21,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
22,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
22,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
22,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
22,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
24,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
24,2,Migraine,Migraine headaches,Headaches,Nerv,N
24,3,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
24,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
25,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
26,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
27,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
27,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
28,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
29,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
30,1,Bradypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
30,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
31,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
31,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
31,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
32,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
32,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
33,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
34,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
35,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
36,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
36,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
36,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
36,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
36,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
37,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
38,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
38,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
39,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
40,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
41,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
42,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
43,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
43,2,Headache,Headaches NEC,Headaches,Nerv,N
43,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
45,2,Headache,Headaches NEC,Headaches,Nerv,N
45,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
46,1,Migraine,Migraine headaches,Headaches,Nerv,N
47,1,Dissociation,Dissociative states,Dissociative disorders,Psych,N
47,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
47,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
47,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
48,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
49,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
50,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
51,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
52,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
52,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
54,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
54,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
56,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
57,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
58,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
59,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
59,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
59,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
59,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
60,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
60,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
61,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
62,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
62,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
62,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
62,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
63,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
64,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
65,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
66,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
67,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
67,2,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
67,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
67,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
68,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
68,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
68,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
68,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
69,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
69,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
70,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
72,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
72,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
73,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
73,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
73,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
73,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
73,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
73,6,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
74,1,Cheyne-Stokes respiration,Breathing abnormalities,Respiratory disorders NEC,Resp,N
74,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
74,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
74,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
75,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
76,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
77,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
77,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
77,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
78,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
79,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
81,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
83,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
83,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
84,1,Headache,Headaches NEC,Headaches,Nerv,N
84,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
84,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
85,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
85,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
85,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
86,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
87,1,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
88,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
89,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
90,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
90,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
90,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
91,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
92,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
93,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
93,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
94,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
94,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
94,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
95,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
96,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
96,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
96,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
96,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
96,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
97,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
99,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
99,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
100,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
100,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
100,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
101,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
101,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
101,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
102,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
103,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
103,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
104,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
104,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
104,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
105,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
107,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
107,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
108,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
108,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
109,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
110,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
111,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
112,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
112,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
112,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
113,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
114,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
115,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
116,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
116,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
116,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
117,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
117,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
117,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
118,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
119,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
120,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
120,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
121,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
121,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
121,3,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
121,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
123,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
124,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
124,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
125,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
125,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
126,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
127,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
127,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
127,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
128,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
128,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
129,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,1,Headache,Headaches NEC,Headaches,Nerv,N
130,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
130,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
130,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
131,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
131,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
131,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
131,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
132,1,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
133,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
133,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
133,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
134,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
135,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
136,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
136,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
137,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
137,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
137,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
138,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
138,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
138,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
139,1,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
139,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
140,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
140,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
140,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
140,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
141,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
141,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
141,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
141,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
141,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
141,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
142,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
142,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
142,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
143,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
143,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
144,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
144,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
144,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
144,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
144,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
145,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
145,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
146,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
147,1,Headache,Headaches NEC,Headaches,Nerv,N
147,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
148,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
149,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
149,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
149,3,Yawning,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
150,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
150,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
151,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
152,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
153,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
153,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
153,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
154,1,Headache,Headaches NEC,Headaches,Nerv,N
155,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
155,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
156,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
157,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
157,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
157,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
157,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
157,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
158,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
159,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
159,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
159,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
160,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
160,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
160,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
161,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
161,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
161,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
162,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
163,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
164,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
165,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
166,1,Headache,Headaches NEC,Headaches,Nerv,N
167,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
168,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
169,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
170,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
172,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
173,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
173,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
174,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
175,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
176,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
177,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
177,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
178,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
179,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
179,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
180,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
181,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
181,2,Headache,Headaches NEC,Headaches,Nerv,N
181,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
181,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
182,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
182,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
182,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
183,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
183,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
184,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
184,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
184,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
185,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
186,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
186,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
186,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
186,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
187,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
187,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
188,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
189,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
189,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
190,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
190,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
190,3,Headache,Headaches NEC,Headaches,Nerv,N
190,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
191,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
191,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
192,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
192,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
192,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
193,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
193,2,Pituitary tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
194,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
194,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
194,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
194,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
194,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
195,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
195,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
195,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
196,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
197,1,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
197,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
198,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
199,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
199,2,Headache,Headaches NEC,Headaches,Nerv,N
199,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
199,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
200,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
201,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
202,1,Ejaculation disorder,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
203,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
203,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
204,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
204,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
205,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
205,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
206,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
207,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
208,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
208,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
209,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
209,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
209,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
209,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
210,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
210,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
210,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
210,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
211,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
211,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
211,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
211,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
211,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
213,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
214,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
215,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
215,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
215,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
216,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
217,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
217,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
217,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
218,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
218,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
218,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
219,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
219,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
220,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
220,2,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
220,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
221,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
222,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
222,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
223,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
223,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
223,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
224,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
224,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
225,1,Amblyopia,Amblyopic vision impairment,Vision disorders,Eye,N
225,2,Headache,Headaches NEC,Headaches,Nerv,N
225,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
226,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
226,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
227,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
227,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
227,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
228,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
229,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
230,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
230,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
231,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
231,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
232,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
232,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
232,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
233,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
233,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
234,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
234,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
234,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
235,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
236,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
236,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
237,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
237,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
238,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
238,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
238,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
238,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
239,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
239,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
239,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
240,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
240,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
240,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
241,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
242,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
242,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
243,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
243,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
243,3,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
243,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
244,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
244,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
244,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
245,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
245,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
246,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
246,2,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
247,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
248,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
249,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
250,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
251,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
251,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
251,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
252,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
253,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
253,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
253,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
253,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
254,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
254,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
255,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
256,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
257,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
257,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
257,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
258,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
258,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
258,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
259,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
259,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
260,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
260,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
261,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
262,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
262,2,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
263,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
263,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
264,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
264,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
265,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
265,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
265,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
266,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
266,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
267,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
267,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
268,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
268,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
269,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
269,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
270,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
271,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
272,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
272,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
272,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
273,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
274,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
275,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
276,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
276,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
276,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
277,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
278,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
278,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
278,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
279,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
279,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
280,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
280,2,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
280,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
281,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
281,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
281,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
281,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
282,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
283,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
284,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
284,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
284,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
285,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
285,2,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
286,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
286,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
287,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
287,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
288,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
289,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
289,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
289,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
289,4,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
290,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
290,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
291,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
292,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
293,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
293,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
294,1,Migraine,Migraine headaches,Headaches,Nerv,N
295,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
295,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
296,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
296,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
297,1,Headache,Headaches NEC,Headaches,Nerv,N
298,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
299,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
299,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
299,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
300,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
300,2,Headache,Headaches NEC,Headaches,Nerv,N
300,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
301,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
302,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
302,2,Headache,Headaches NEC,Headaches,Nerv,N
302,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
302,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
303,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
304,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
304,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
305,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
305,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
306,1,Headache,Headaches NEC,Headaches,Nerv,N
306,2,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
306,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
307,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
307,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
307,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
308,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
309,1,Accommodation disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
310,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
310,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
310,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
311,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
311,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
312,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
313,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
313,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
314,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
315,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
315,2,Headache,Headaches NEC,Headaches,Nerv,N
315,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
316,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
316,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
316,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
316,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
317,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
318,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
319,1,Headache,Headaches NEC,Headaches,Nerv,N
319,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
319,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
319,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
320,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
320,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
321,1,Headache,Headaches NEC,Headaches,Nerv,N
321,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
321,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
322,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
323,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
324,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
325,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
326,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
326,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
327,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
327,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
328,1,Headache,Headaches NEC,Headaches,Nerv,N
328,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
329,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
329,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
330,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
331,1,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
331,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
332,1,Headache,Headaches NEC,Headaches,Nerv,N
332,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
332,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
333,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
334,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
334,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
335,1,Headache,Headaches NEC,Headaches,Nerv,N
335,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
335,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
335,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
336,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
336,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
336,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
337,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
337,2,Headache,Headaches NEC,Headaches,Nerv,N
337,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
338,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
338,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
339,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
340,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
340,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
340,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
341,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
342,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
343,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
343,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
343,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
343,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
343,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
343,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
344,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
344,2,Headache,Headaches NEC,Headaches,Nerv,N
344,3,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
344,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
345,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
346,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
347,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
347,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
347,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
347,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
347,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
348,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
349,1,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
349,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
350,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
350,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
350,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
350,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
351,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
351,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
352,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
352,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
352,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
352,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
353,1,Headache,Headaches NEC,Headaches,Nerv,N
353,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
353,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
353,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
354,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
354,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
355,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
356,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
357,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
358,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
358,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
359,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
360,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
360,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
361,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
362,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
362,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
363,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
364,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
364,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
364,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
365,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
365,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
365,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
366,1,Headache,Headaches NEC,Headaches,Nerv,N
367,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
368,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
369,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
370,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
370,2,Headache,Headaches NEC,Headaches,Nerv,N
371,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
371,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
371,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
372,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
372,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
373,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
373,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
374,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
375,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
376,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
377,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
377,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
378,1,Deafness,Hearing losses,Hearing disorders,Ear,N
378,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
378,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
378,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
378,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
379,1,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
380,1,Headache,Headaches NEC,Headaches,Nerv,N
380,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
380,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
380,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
380,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
381,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
381,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
382,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
382,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
382,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
382,4,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
382,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
383,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
383,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
383,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
383,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
383,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
384,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
384,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
384,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
385,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
385,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
385,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
385,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
386,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
386,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
386,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
386,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
387,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
387,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
387,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
387,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
387,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
388,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
388,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
389,1,Headache,Headaches NEC,Headaches,Nerv,N
389,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
389,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
390,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
390,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
391,1,Headache,Headaches NEC,Headaches,Nerv,N
391,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
392,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
392,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
393,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
393,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
394,1,Headache,Headaches NEC,Headaches,Nerv,N
394,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
394,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
395,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
395,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
395,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
396,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
397,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
397,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
398,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
398,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
398,3,Headache,Headaches NEC,Headaches,Nerv,N
398,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
399,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
400,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
401,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
402,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
402,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
402,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
403,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
403,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
404,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
405,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
406,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
407,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
407,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
408,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
408,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
409,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
409,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
409,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
410,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
411,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
411,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
411,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
412,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
413,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
414,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
414,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
414,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
414,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
414,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
415,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
415,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
415,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
415,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
415,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
416,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
417,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
417,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
418,1,Headache,Headaches NEC,Headaches,Nerv,N
418,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
418,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
419,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
419,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
420,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
421,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
421,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
421,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
421,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
422,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
423,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
423,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
424,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
424,2,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
425,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
426,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
426,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
427,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
427,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
427,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
428,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
428,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
429,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
429,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
430,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
431,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
432,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
433,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
434,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
434,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
435,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
435,2,Headache,Headaches NEC,Headaches,Nerv,N
435,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
435,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
436,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
437,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
438,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
438,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
438,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
439,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
439,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
439,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
440,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
441,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
442,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
443,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
443,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
444,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
444,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
444,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
445,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
445,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
445,3,Headache,Headaches NEC,Headaches,Nerv,N
445,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
446,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
446,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
446,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
446,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
447,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
447,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
447,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
448,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
448,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
448,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
449,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
450,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
451,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
451,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
452,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
452,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
452,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
452,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
453,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
453,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
454,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
454,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
454,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
455,1,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
455,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
456,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
457,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
457,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
457,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
458,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
458,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
459,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
459,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
460,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
460,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
460,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
461,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
461,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
462,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
463,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
463,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
463,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
464,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
464,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
465,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
466,1,Headache,Headaches NEC,Headaches,Nerv,N
466,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
467,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
468,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
468,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
469,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
469,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
469,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
470,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
471,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
472,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
472,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
473,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
473,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
474,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
475,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
476,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
476,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
477,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
477,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
478,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
478,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
479,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
480,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
480,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
480,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
481,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
482,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
482,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
483,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
483,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
484,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
485,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
486,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
486,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
486,3,Headache,Headaches NEC,Headaches,Nerv,N
486,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
487,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
488,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
488,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
488,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
489,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
489,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
489,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
489,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
490,1,Amblyopia,Amblyopic vision impairment,Vision disorders,Eye,N
490,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
490,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
490,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
490,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
491,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
492,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
492,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
493,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
494,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
495,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
496,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
497,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
498,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
499,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
500,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
500,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
501,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
501,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
501,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
502,1,Headache,Headaches NEC,Headaches,Nerv,N
502,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
502,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
502,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
503,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
504,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
504,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
504,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
505,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
506,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
506,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
507,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
507,2,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
507,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
507,4,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
507,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
508,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
508,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
509,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
509,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
509,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
510,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
510,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
510,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
511,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
512,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
512,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
513,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
513,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
514,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
515,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
516,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
516,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
516,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
516,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
517,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
517,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
517,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
518,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
518,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
518,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
519,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
519,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
519,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
519,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
520,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
521,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
521,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
522,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
523,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
523,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
524,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
525,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
526,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
527,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
528,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
528,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
529,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
529,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
529,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
530,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
530,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
530,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
531,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
531,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
532,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
532,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
533,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
534,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
534,2,Inner ear disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
534,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
535,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
535,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
535,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
536,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
537,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
538,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
539,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
540,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
540,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
541,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
541,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
542,1,Headache,Headaches NEC,Headaches,Nerv,N
542,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
543,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
543,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
544,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
545,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
545,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
546,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
546,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
547,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
548,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
548,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
548,3,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
549,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
549,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
550,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
551,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
551,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
552,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
552,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
552,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
553,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
553,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
553,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
554,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
554,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
555,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
555,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
555,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
556,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
556,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
556,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
557,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
557,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
557,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
558,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
558,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
559,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
560,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
560,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
560,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
561,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
561,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
562,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
562,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
563,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
563,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
564,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
565,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
565,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
565,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
566,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
566,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
566,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
567,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
568,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
568,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
568,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
568,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
568,5,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
568,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
568,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
568,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
569,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
570,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
570,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
571,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
572,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
572,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
572,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
573,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
573,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
573,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
573,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
574,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
574,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
574,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
575,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
576,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
576,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
576,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
576,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
577,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
578,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
578,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
579,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
579,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
580,1,Amblyopia,Amblyopic vision impairment,Vision disorders,Eye,N
580,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
580,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
580,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
581,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
581,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
582,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
582,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
583,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
583,2,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
584,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
584,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
584,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
584,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
584,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
585,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
585,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
585,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
585,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
586,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
587,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
588,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
588,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
588,3,Headache,Headaches NEC,Headaches,Nerv,N
588,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
589,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
589,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
590,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
590,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
590,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
590,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
591,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
591,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
591,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
592,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
593,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
593,2,Headache,Headaches NEC,Headaches,Nerv,N
593,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
593,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
594,1,Headache,Headaches NEC,Headaches,Nerv,N
594,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
594,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
594,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
594,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
595,1,Accommodation disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
595,2,Headache,Headaches NEC,Headaches,Nerv,N
595,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
595,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
595,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
596,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
596,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
597,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
598,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
598,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
599,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
600,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
600,2,Headache,Headaches NEC,Headaches,Nerv,N
601,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
602,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
602,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
603,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
603,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
604,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
604,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
604,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
604,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
605,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
606,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
606,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
606,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
607,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
608,1,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
609,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
609,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
610,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
611,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
612,1,Bradypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
612,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
612,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
613,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
614,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
614,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
615,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
615,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
615,3,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
616,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
616,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
617,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
617,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
618,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
619,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
619,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
619,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
620,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
621,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
621,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
621,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
622,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
623,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
623,2,Oesophageal stenosis,Oesophageal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
624,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
625,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
625,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
626,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
626,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
627,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
628,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
629,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
629,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
630,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
630,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
630,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
631,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
631,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
632,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
632,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
632,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
633,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
634,1,Migraine,Migraine headaches,Headaches,Nerv,N
635,1,Headache,Headaches NEC,Headaches,Nerv,N
635,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
635,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
635,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
636,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
637,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
638,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
639,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
640,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
641,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
641,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
641,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
641,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
642,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
643,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
644,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
645,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
645,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
646,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
646,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
647,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
647,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
648,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
648,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
649,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
649,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
650,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
650,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
650,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
650,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
651,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
652,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
653,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
653,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
653,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
653,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
654,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
654,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
654,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
654,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
654,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
655,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
656,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
656,2,Headache,Headaches NEC,Headaches,Nerv,N
656,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
657,1,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
658,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
659,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
660,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
661,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
661,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
662,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
663,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
663,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
664,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
664,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
664,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
665,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
665,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
665,3,Headache,Headaches NEC,Headaches,Nerv,N
666,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
667,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
668,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
668,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
669,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
670,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
671,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
672,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
672,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
672,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
672,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
673,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
674,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
674,2,Headache,Headaches NEC,Headaches,Nerv,N
674,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
675,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
675,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
676,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
676,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
677,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
677,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
677,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
678,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
678,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
678,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
678,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
679,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
680,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
680,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
680,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
680,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
680,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
681,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
681,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
681,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
681,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
682,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
683,1,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
684,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
685,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
685,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
685,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
685,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
685,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
686,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
686,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
686,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
686,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
686,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
686,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
687,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
687,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
687,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
688,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
689,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
690,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
690,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
690,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
691,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
692,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
692,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
693,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
694,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
695,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
695,2,Hypoventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
695,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
695,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
696,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
697,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
697,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
697,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
698,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
698,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
698,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
698,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
699,1,Headache,Headaches NEC,Headaches,Nerv,N
699,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
699,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
700,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
700,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
700,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
700,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
701,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
701,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
702,1,Headache,Headaches NEC,Headaches,Nerv,N
702,2,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
702,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
702,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
702,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
703,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
703,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
704,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
705,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
705,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
706,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
706,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
706,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
706,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
706,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
707,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
707,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
708,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
708,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
709,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
709,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
710,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
711,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
711,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
712,1,Deafness,Hearing losses,Hearing disorders,Ear,N
712,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
713,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
714,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
715,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
716,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
716,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
716,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
717,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
717,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
717,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
718,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
718,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
718,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
718,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
719,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
720,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
721,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
721,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
722,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
723,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
723,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
723,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
724,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
725,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
725,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
725,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
726,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
726,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
726,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
727,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
727,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
727,3,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
728,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
729,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
729,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
730,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
731,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
731,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
732,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
733,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
734,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
734,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
735,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
735,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
735,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
736,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
736,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
737,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
737,2,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
738,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
739,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
740,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
741,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
741,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
742,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
742,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
743,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
743,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
744,1,Headache,Headaches NEC,Headaches,Nerv,N
744,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
744,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
745,1,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
746,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
747,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
747,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
748,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
748,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
749,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
750,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
750,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
751,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
752,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
752,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
753,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
753,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
753,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
753,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
753,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
753,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
754,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
754,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
755,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
756,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
756,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
757,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
758,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
758,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
758,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
759,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
760,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
761,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
761,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
762,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
763,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
764,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
764,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
765,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
765,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
766,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
766,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
767,1,Cranial nerve disorder,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
767,2,Migraine,Migraine headaches,Headaches,Nerv,N
767,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
767,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
768,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
768,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
768,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
769,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
769,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
769,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
770,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
771,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
771,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
771,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
771,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
771,5,Urinary hesitation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
771,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
772,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
773,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
773,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
773,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
774,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
774,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
774,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
774,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
775,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
775,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
775,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
776,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
776,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
777,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
778,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
779,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
779,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
779,3,Headache,Headaches NEC,Headaches,Nerv,N
779,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
779,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
779,6,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
779,7,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
779,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
779,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
780,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
781,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
781,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
782,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
783,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
784,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
784,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
785,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
785,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
786,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
786,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
786,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
787,1,Headache,Headaches NEC,Headaches,Nerv,N
787,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
788,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
788,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
788,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
789,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
789,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
789,3,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
790,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
790,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
790,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
791,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
791,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
792,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
792,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
793,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
793,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
793,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
793,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
794,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
794,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
794,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
795,1,Cheyne-Stokes respiration,Breathing abnormalities,Respiratory disorders NEC,Resp,N
795,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
795,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
796,1,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
796,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
797,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
798,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
799,1,Headache,Headaches NEC,Headaches,Nerv,N
799,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
799,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
800,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
800,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
801,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
802,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
802,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
803,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
804,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
804,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
805,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
806,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
807,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
807,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
808,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
808,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
809,1,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
810,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
811,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
812,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
813,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
814,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
814,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
815,1,Opisthotonus,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
816,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
817,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
817,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
817,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
818,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
818,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
818,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
818,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
819,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
819,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
819,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
819,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
820,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
820,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
821,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
822,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
823,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
824,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
824,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
824,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
824,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
825,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
825,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
825,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
826,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
826,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
827,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
828,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
829,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
829,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
830,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
831,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
832,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
832,2,Headache,Headaches NEC,Headaches,Nerv,N
832,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
832,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
832,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
833,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
833,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
833,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
834,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
834,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
835,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
836,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
837,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
837,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
838,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
838,2,Headache,Headaches NEC,Headaches,Nerv,N
838,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
838,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
838,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
838,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
839,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
839,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
840,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
840,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
840,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
841,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
841,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
841,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
841,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
841,5,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
841,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
842,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
842,2,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
843,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
843,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
844,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
845,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
845,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
845,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
845,4,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
846,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
847,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
847,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
847,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
848,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
848,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
848,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
849,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
849,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
850,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
850,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
851,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
851,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
852,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
853,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
854,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
855,1,Bundle branch block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
855,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
856,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
856,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
857,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
858,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
859,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
859,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
859,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
860,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
860,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
861,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
861,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
861,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
861,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
861,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
862,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
862,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
862,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
862,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
862,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
862,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
862,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
863,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
864,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
864,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
865,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
866,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
866,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
866,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
867,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
868,1,Headache,Headaches NEC,Headaches,Nerv,N
868,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
869,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
869,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
869,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
870,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
871,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
872,1,Headache,Headaches NEC,Headaches,Nerv,N
873,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
874,1,Asphyxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
874,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
874,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
874,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
875,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
876,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
877,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
878,1,Libido increased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
879,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
879,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
879,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
879,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
879,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
880,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
880,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
880,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
881,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
882,1,Cranial nerve disorder,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
882,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
883,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
884,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
884,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
884,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
885,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
886,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
887,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
887,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
887,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
887,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
888,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
889,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
890,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
890,2,Headache,Headaches NEC,Headaches,Nerv,N
890,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
890,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
891,1,Headache,Headaches NEC,Headaches,Nerv,N
892,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
893,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
893,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
894,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
895,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
896,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
897,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
898,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
898,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
899,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
900,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
900,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
901,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
901,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
902,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
902,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
903,1,Headache,Headaches NEC,Headaches,Nerv,N
904,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
905,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
906,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
906,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
906,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
907,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
907,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
907,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
907,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
908,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
909,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
910,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
910,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
910,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
911,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
911,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
911,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
912,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
912,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
913,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
913,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
913,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
914,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
915,1,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
915,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
915,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
915,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
915,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
915,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
916,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
917,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
918,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
918,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
919,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
919,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
920,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
921,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
921,2,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
922,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
923,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
924,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
925,1,Headache,Headaches NEC,Headaches,Nerv,N
926,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
926,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
927,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
927,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
928,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
928,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
928,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
928,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
928,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
929,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
930,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
930,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
931,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
932,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
932,2,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
932,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
933,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
934,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
935,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
935,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
935,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
935,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
935,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
936,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
936,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
937,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
938,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
939,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
939,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
940,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
941,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
942,1,Accidental poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
942,2,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
942,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
943,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
943,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
943,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
944,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
945,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
945,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
946,1,Deafness,Hearing losses,Hearing disorders,Ear,N
947,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
948,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
948,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
948,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
949,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
949,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
949,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
949,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
949,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
950,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
950,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
950,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
950,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
950,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
950,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
950,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
951,1,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
952,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
952,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
952,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
953,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
953,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
953,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
953,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
954,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
954,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
955,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
956,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
957,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
957,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
957,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
958,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
959,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
959,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
960,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
961,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
961,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
962,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
962,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
963,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
964,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
965,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
965,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
965,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
966,1,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
966,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
966,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
967,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
967,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
968,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
969,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
969,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
969,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
969,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
969,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
970,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
970,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
970,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
970,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
970,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
971,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
971,2,Headache,Headaches NEC,Headaches,Nerv,N
971,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
971,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
971,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
972,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
972,2,Headache,Headaches NEC,Headaches,Nerv,N
972,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
973,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
974,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
975,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
976,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
976,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
976,3,Headache,Headaches NEC,Headaches,Nerv,N
976,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
977,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
977,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
977,3,Headache,Headaches NEC,Headaches,Nerv,N
977,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
978,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
979,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
980,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
980,2,Hair disorder,Pilar disorders NEC,Skin appendage conditions,Skin,N
980,3,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
981,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
982,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
983,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
984,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
984,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
985,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
986,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
986,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
986,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
987,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
988,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
988,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
989,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
990,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
991,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
992,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
993,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
994,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
994,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
995,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
996,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
996,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
996,3,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
996,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
997,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
998,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
999,1,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1000,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1001,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1002,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1003,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1004,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1004,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1005,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1005,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1006,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1007,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1007,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1007,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1007,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1008,1,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1009,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1009,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1010,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1011,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1011,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1011,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1012,1,Headache,Headaches NEC,Headaches,Nerv,N
1013,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1013,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1014,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1015,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1016,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1017,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1018,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1018,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1018,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1018,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1019,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1020,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1020,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1021,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1022,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1023,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1023,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1024,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1024,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1025,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1025,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1025,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1025,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1025,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1026,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1027,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1027,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1027,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1028,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1028,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1028,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1028,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1029,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1030,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1031,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1031,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1031,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1032,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1033,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1033,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1034,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1034,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1034,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1035,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
1035,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1036,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1036,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1036,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1036,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1037,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1037,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1037,3,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1037,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1037,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1037,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1038,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1038,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1039,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1040,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1040,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1041,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1041,2,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1042,1,Dissociation,Dissociative states,Dissociative disorders,Psych,N
1042,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1043,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1043,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1043,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1044,1,Capillaritis,Skin vasculitides,Skin vascular abnormalities,Skin,N
1044,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1044,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1045,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1045,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1046,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1047,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1047,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1047,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1048,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1048,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1049,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1050,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1051,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1052,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1052,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1053,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1053,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1053,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1054,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1055,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1056,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1057,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1058,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1059,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1060,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1060,2,Testicular disorder,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
1061,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1061,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1061,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1061,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1062,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1063,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
1064,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1065,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1065,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1066,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1067,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1067,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1067,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1068,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1068,2,Urine analysis abnormal,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1069,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1069,2,Lip oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1069,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1069,4,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
1070,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1070,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1071,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1071,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1071,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1072,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1072,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1072,3,Migraine,Migraine headaches,Headaches,Nerv,N
1072,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1072,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1073,1,Congenital ectopic bladder,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1074,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1075,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1075,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1076,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1077,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1078,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1078,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1078,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1078,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1079,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1080,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1081,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1082,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1082,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1083,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1084,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1085,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1086,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1087,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1088,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1089,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1089,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1090,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1091,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1091,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1092,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1093,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1094,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1094,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1095,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1095,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1095,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1096,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1096,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1096,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1097,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1097,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1098,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1099,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1099,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1100,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1101,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1102,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1102,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1103,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1104,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1104,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1104,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1105,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1105,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1106,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1106,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1106,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1106,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1106,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1107,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1107,2,Hypervigilance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1108,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1108,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1108,3,Immobile,Disability issues,Lifestyle issues,SocCi,N
1108,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1109,1,Abortion missed,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
1110,1,Application site eczema,Application site reactions,Administration site reactions,Genrl,N
1110,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1111,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1112,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1112,2,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1113,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1114,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1114,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1115,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1115,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1115,3,Headache,Headaches NEC,Headaches,Nerv,N
1115,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1116,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1117,1,Headache,Headaches NEC,Headaches,Nerv,N
1118,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1118,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1119,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1120,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1120,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1121,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1121,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1121,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1121,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1121,5,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1121,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1122,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1122,2,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1122,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1123,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1124,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1125,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1126,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1126,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1126,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1127,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1127,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1127,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1128,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1129,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1129,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1130,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1130,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1130,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1130,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1131,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1131,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1132,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1132,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1133,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1134,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1134,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1134,3,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1135,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1136,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1137,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1138,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1139,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1140,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1140,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1140,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1141,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1142,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1142,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1142,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1142,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1143,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1143,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1143,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1143,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1143,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1143,6,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1143,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1143,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1144,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1145,1,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1145,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1146,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1146,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1146,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1147,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1148,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1148,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1148,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1149,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1150,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1151,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1151,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
1152,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1152,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1153,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1153,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1153,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1153,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1154,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1154,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1154,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1155,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1156,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1156,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1156,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1156,4,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1156,5,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1156,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1156,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1157,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1158,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
1158,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1159,1,Enamel anomaly,Dental surface disorders,Dental and gingival conditions,Gastr,N
1160,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1161,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1161,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1162,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1162,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1163,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1164,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1165,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1165,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1166,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1167,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1167,2,Headache,Headaches NEC,Headaches,Nerv,N
1167,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1167,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1168,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1168,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1169,1,Drug screen positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
1169,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1169,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1170,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1170,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
1171,1,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1172,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1173,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1173,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1173,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1174,1,Enamel anomaly,Dental surface disorders,Dental and gingival conditions,Gastr,N
1174,2,Tooth malformation,Dental developmental disorders and anomalies,Dental and gingival conditions,Gastr,N
1175,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1176,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1176,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1176,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1177,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1177,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1178,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1178,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1179,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1180,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1180,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1180,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1180,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1180,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1180,6,Oedema mucosal,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1181,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1182,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1183,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1184,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1184,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1184,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1184,4,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1184,5,Headache,Headaches NEC,Headaches,Nerv,N
1184,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1184,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1184,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1184,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1185,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1186,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1186,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1187,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1188,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1188,2,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1189,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1190,1,Headache,Headaches NEC,Headaches,Nerv,N
1191,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1191,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1191,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1192,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1192,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1192,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1193,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1194,1,Hyperkinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1194,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1195,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1195,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1196,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1197,1,Palmar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1197,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1197,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1198,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1198,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1199,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1200,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1200,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1200,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1201,1,Hyperkinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1202,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1202,2,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1202,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1203,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1203,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1203,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1204,1,Headache,Headaches NEC,Headaches,Nerv,N
1205,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1205,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1205,3,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
1206,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1207,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1207,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1207,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1208,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1208,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1209,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1210,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1210,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1211,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1211,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1211,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1211,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1211,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1212,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1212,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1212,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1212,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1212,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1213,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1214,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1215,1,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1215,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1215,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1216,1,Eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
1216,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1217,1,Migraine,Migraine headaches,Headaches,Nerv,N
1217,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1218,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1218,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1219,1,Headache,Headaches NEC,Headaches,Nerv,N
1219,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1219,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1219,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1220,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1220,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1220,3,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1220,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1220,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1221,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1221,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1222,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1222,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1222,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1222,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1223,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1223,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1223,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1224,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1224,2,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1224,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1225,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1225,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1225,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1226,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1227,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1228,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1229,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1229,2,Headache,Headaches NEC,Headaches,Nerv,N
1229,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1230,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1230,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1230,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1230,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1230,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1231,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1231,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1232,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1233,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1233,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1233,3,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1234,1,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1234,2,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
1235,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1235,2,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
1236,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1236,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1237,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1238,1,Anorgasmia,Orgasmic disorders and disturbances,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1239,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1240,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1241,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1241,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1241,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1242,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1243,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1244,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1244,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1244,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1245,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1245,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1245,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1245,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1245,5,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1246,1,Biliary colic,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1246,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1246,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1247,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1248,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1248,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1248,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1249,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1250,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1250,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1250,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1251,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1251,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1251,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1252,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1252,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1252,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1252,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1252,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1253,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1253,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1253,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1253,4,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1253,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1254,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1254,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1254,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1254,4,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1255,1,Application site eczema,Application site reactions,Administration site reactions,Genrl,N
1255,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1255,3,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1256,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1257,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1257,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1257,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1257,4,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1257,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1257,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1257,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1257,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1257,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1257,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1257,11,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1257,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1258,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1258,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1258,3,Headache,Headaches NEC,Headaches,Nerv,N
1258,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1259,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1259,2,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1260,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1260,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1260,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1261,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1261,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1262,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1263,1,Headache,Headaches NEC,Headaches,Nerv,N
1264,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1265,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1265,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1266,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1267,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1268,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1268,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1268,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1269,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1269,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1269,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1270,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1270,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1270,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1270,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1271,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1272,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1272,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1272,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1272,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1273,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1273,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1273,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1273,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1273,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1274,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1274,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1275,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1275,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1276,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1277,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1277,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1277,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1278,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1279,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1280,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1280,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1280,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1280,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1281,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1281,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1281,3,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1282,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1283,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1284,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1285,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1286,1,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1286,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1287,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1287,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1288,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1288,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1288,3,Headache,Headaches NEC,Headaches,Nerv,N
1288,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1289,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1289,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1290,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1290,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1290,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1290,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1291,1,Cardiac valve disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
1291,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1291,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1292,1,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
1293,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1293,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1294,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1294,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1294,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1295,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1296,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1296,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1296,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1296,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1297,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1298,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1299,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1299,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1299,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1299,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1299,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1300,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1300,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1301,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1302,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1302,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1303,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1304,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1305,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1305,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1305,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1305,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1306,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1307,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1307,2,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1307,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1308,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1309,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1310,1,Device failure,Device issues NEC,Device issues,Prod,N
1311,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1312,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1312,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1312,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1312,4,Headache,Headaches NEC,Headaches,Nerv,N
1313,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1313,2,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1313,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1314,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1314,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1315,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1316,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1316,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1316,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1316,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1317,1,Aortic stenosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1317,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1318,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1318,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1319,1,Pruritus allergic,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1320,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1320,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1320,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1320,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1321,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1321,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1322,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1322,2,Application site mass,Application site reactions,Administration site reactions,Genrl,N
1322,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1323,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1323,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1323,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1324,1,Headache,Headaches NEC,Headaches,Nerv,N
1325,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1326,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1326,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1327,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1328,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1328,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1328,3,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1328,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1328,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1328,6,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1328,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1328,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1329,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1330,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1330,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1331,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1331,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1331,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1332,1,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1332,2,Immobile,Disability issues,Lifestyle issues,SocCi,N
1333,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1333,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1334,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1334,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1334,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1334,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1334,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1334,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1335,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1335,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1336,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1336,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1336,3,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
1337,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1337,2,Tongue erythema,Tongue signs and symptoms,Tongue conditions,Gastr,N
1338,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1339,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1339,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1340,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1341,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1341,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1341,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1341,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1342,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1342,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1342,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1342,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1342,5,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1342,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1342,7,Headache,Headaches NEC,Headaches,Nerv,N
1342,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1343,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1344,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1345,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1346,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1346,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1346,3,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1346,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1347,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1347,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1347,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1347,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1347,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1347,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1347,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1348,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1349,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1350,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1351,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1352,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1352,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1353,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1353,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1354,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
1354,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1355,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1356,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1356,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1356,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1356,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1356,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1356,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1357,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1357,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1358,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1359,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1359,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1360,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1360,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1361,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1361,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1362,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1362,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1362,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1362,4,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1363,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1364,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1364,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1364,3,Foot deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1364,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1364,5,Hand deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1364,6,Jaw disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1364,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
1364,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1364,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1365,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1365,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1366,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1366,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1367,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1367,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1367,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1368,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1368,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1368,3,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1369,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1369,2,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1369,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1370,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1370,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1371,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
1372,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
1373,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1373,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1374,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1374,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1374,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1374,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1374,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1374,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
1374,7,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1374,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1375,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1375,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1376,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1377,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1377,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1378,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1379,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1379,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1379,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1380,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1380,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1380,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1380,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1381,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1381,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1382,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1382,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1382,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1383,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1384,1,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1384,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1385,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
1385,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1386,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1387,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1387,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1387,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1388,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1388,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1388,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1388,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1388,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1389,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
1389,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1389,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1389,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1389,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1389,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1390,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1390,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1391,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1391,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1392,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1392,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1392,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1392,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1392,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1392,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1392,7,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1393,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1394,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1394,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1394,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1394,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1394,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1395,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1396,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1396,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1396,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1397,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1397,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1397,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1398,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1398,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1398,3,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1399,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1400,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1401,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1401,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1402,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1403,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
1403,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1404,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1404,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1404,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1405,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1405,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1405,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1406,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1407,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1407,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1408,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1408,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
1409,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1410,1,Application site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1410,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1410,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1410,4,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1411,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1411,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1412,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1412,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1412,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1412,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1413,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1413,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1414,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1414,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1415,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1415,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1415,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1416,1,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1416,2,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1416,3,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1416,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1417,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1418,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1418,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1418,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1418,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1419,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1420,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1421,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1421,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1421,3,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1422,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1423,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1423,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1424,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1424,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1424,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1425,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1426,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1427,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1428,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1428,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1428,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1428,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1428,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1428,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1429,1,Headache,Headaches NEC,Headaches,Nerv,N
1429,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1430,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1430,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1430,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1430,4,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1430,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1430,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1430,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1431,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1432,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1432,2,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1433,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1433,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1433,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1433,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1434,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1434,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1435,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1436,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
1436,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1436,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1437,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1437,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1437,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1437,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1437,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1437,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1438,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1438,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1438,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1438,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1439,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1439,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1439,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,Y
1440,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1441,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1441,2,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
1441,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1441,4,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1441,5,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1441,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1441,7,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1442,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1442,2,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1443,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1444,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1444,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1445,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1445,2,Motion sickness,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1445,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1445,4,Tension headache,Headaches NEC,Headaches,Nerv,N
1446,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1446,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1447,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1448,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1448,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1448,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1448,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1448,5,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1448,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1449,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1449,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1449,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1450,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1451,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1451,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1452,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1453,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1454,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1455,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1455,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1455,3,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
1456,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1457,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1457,2,Headache,Headaches NEC,Headaches,Nerv,N
1457,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1457,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1458,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1458,2,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1458,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1458,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1459,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1459,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1459,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1460,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1461,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1461,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1461,3,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1461,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1461,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1461,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1462,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1462,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1463,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1464,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1464,2,Tongue haemorrhage,Tongue disorders,Tongue conditions,Gastr,N
1465,1,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1465,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1466,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1466,2,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
1466,3,Tongue haemorrhage,Tongue disorders,Tongue conditions,Gastr,N
1467,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1467,2,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1467,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1467,4,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1467,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1467,6,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1467,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1467,8,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1467,9,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1467,10,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1467,11,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1467,12,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1467,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1467,14,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1467,15,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1467,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1467,17,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1467,18,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1467,19,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1467,20,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1467,21,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1467,22,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1467,23,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1468,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1468,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1468,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1468,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1469,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
1469,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1469,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1470,1,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1470,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1470,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1470,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1471,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1471,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1472,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1473,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1473,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1473,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1473,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1473,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1473,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1473,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1474,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1474,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1474,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1475,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1475,2,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
1476,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1477,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1477,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1477,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1478,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1478,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1478,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1478,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1479,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1480,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1480,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1481,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1481,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1481,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1482,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1483,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1484,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1484,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1485,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1485,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1485,3,Headache,Headaches NEC,Headaches,Nerv,N
1485,4,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1485,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1485,6,Immobile,Disability issues,Lifestyle issues,SocCi,N
1485,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1485,8,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1485,9,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1485,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1486,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1486,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1486,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1486,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1486,5,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
1487,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1487,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1487,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1488,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1488,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1488,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1489,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
1490,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1490,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1490,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1490,4,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1490,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1490,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1490,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1491,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1491,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1492,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1492,2,Exposure via body fluid,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
1492,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1492,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1493,1,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1494,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1494,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1494,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1494,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1495,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1496,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1496,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1496,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1497,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1498,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1498,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
1498,3,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
1498,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1498,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1498,6,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1498,7,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1498,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1499,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1499,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1499,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1500,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1500,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1501,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1501,2,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1501,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1501,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1501,5,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1501,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1501,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1501,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1502,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1502,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1502,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1502,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1502,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1503,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1503,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
1503,3,Drug diversion,Criminal activity,Legal issues,SocCi,N
1503,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1503,5,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1504,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1505,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1505,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1505,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1506,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1507,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1507,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1507,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1507,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1508,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1508,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1508,3,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1508,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1508,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1508,6,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1509,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
1510,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1510,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1511,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1511,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1511,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1511,4,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1511,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1512,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1512,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1513,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1514,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1515,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1516,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1516,2,Logorrhoea,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
1516,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1516,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1516,5,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1516,6,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1517,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1518,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1519,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1519,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1519,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1520,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1520,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1520,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1521,1,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1522,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1522,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1523,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1523,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1523,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1523,4,Headache,Headaches NEC,Headaches,Nerv,N
1523,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1523,6,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
1524,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
1524,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1524,3,Headache,Headaches NEC,Headaches,Nerv,N
1524,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1524,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1525,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
1525,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1525,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1525,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1526,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1526,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1526,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1527,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1527,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1528,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1528,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1529,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1530,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
1531,1,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1531,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1532,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1533,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1533,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1533,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1534,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1534,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1534,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1535,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1536,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1536,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1536,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1537,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1537,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1538,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1539,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1540,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1541,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1542,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1542,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1542,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1542,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1543,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1543,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1543,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1543,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1544,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1544,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1544,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1545,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1545,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1546,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1546,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
1546,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1546,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1547,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1548,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1549,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1549,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1550,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1551,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1552,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1552,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1552,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1553,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1554,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1555,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1555,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1555,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1556,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1557,1,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1557,2,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1558,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1558,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1558,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1559,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1559,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1559,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1559,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1559,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1560,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1561,1,Headache,Headaches NEC,Headaches,Nerv,N
1561,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1561,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1562,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1562,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1563,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1563,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1564,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1564,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1565,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1565,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1565,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1565,4,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1565,5,Headache,Headaches NEC,Headaches,Nerv,N
1565,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1566,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1566,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
1566,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1567,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1567,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1567,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1567,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1568,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1569,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1569,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1569,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1569,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1570,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1571,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1571,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1572,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
1573,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1573,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1573,3,Skin maceration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1573,4,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1574,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1574,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1574,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1574,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1575,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1576,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1577,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1577,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1578,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
1578,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1579,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1579,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1579,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1579,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1579,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1579,6,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1579,7,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1579,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1579,9,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1579,10,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1579,11,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1579,12,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1579,13,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1579,14,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1579,15,Myalgia,Muscle pains,Muscle disorders,Musc,N
1579,16,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1579,17,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1579,18,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1580,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1580,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1581,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1582,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1582,2,Foetal cystic hygroma,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
1582,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1582,4,Micrognathia,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
1582,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1582,6,Poor sucking reflex,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1582,7,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1583,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1583,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1584,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1584,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1585,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1586,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1586,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1587,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1587,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1587,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1588,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1589,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1589,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1590,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1590,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1590,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1591,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1592,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1592,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1593,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1594,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1595,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1596,1,Chest wall abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1596,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1597,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1597,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1598,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1598,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1599,1,Chest wall abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1599,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1600,1,Migraine,Migraine headaches,Headaches,Nerv,N
1601,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1601,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1602,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1602,2,Migraine,Migraine headaches,Headaches,Nerv,N
1602,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1603,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1603,2,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1604,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1604,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1604,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1604,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1604,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1604,6,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1604,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1604,8,Head titubation,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1604,9,Headache,Headaches NEC,Headaches,Nerv,N
1604,10,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1604,11,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1604,12,Moaning,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1604,13,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1604,14,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1604,15,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1604,16,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1604,17,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1604,18,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1604,19,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1605,1,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1605,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1606,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1607,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1608,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1609,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1609,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1609,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1609,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1609,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1610,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1610,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1610,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1610,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1610,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1611,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1611,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1612,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1612,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1612,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1612,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1613,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1613,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1613,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1614,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
1614,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1614,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1615,1,Acute left ventricular failure,Left ventricular failures,Heart failures,Card,Y
1615,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1615,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1615,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1615,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1616,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1616,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1617,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1618,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1618,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1619,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
1619,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1620,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1621,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1621,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1621,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1621,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1621,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1622,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1623,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1624,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1624,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1625,1,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1625,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1626,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1626,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1627,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1627,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1627,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1627,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1628,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1628,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1628,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1629,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1630,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1630,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1630,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1630,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1630,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1630,6,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1631,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1631,2,Tongue movement disturbance,Tongue signs and symptoms,Tongue conditions,Gastr,N
1632,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1632,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1633,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1633,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1634,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1635,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1636,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1636,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1636,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1637,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1637,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1637,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1637,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1637,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1637,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1637,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1637,8,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1637,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1638,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1638,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1639,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1639,2,Saliva altered,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1639,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1640,1,Bone cancer,Bone neoplasms malignant (excl sarcomas),Skeletal neoplasms malignant and unspecified,Neopl,N
1641,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1641,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1642,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1643,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1643,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1643,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1644,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1644,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1644,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1644,4,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1644,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1644,6,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1644,7,Dissociation,Dissociative states,Dissociative disorders,Psych,N
1644,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1644,9,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1644,10,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1644,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1644,12,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1644,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1644,14,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1644,15,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1644,16,Headache,Headaches NEC,Headaches,Nerv,N
1644,17,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1644,18,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1644,19,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1644,20,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1644,21,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1644,22,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1644,23,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1644,24,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1644,25,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1644,26,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1644,27,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1645,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1645,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1645,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1646,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1646,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1646,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1647,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1647,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1647,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1647,4,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1647,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1647,6,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1647,7,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1647,8,Dissociation,Dissociative states,Dissociative disorders,Psych,N
1647,9,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1647,10,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1647,11,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1647,12,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1647,13,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1647,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1647,15,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1647,16,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1647,17,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1647,18,Headache,Headaches NEC,Headaches,Nerv,N
1647,19,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1647,20,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1647,21,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1647,22,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1647,23,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1647,24,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1647,25,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1647,26,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1647,27,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1647,28,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1647,29,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1648,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1648,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1649,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1650,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1651,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1651,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1652,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1653,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1654,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1654,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1654,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1654,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1655,1,Acute left ventricular failure,Left ventricular failures,Heart failures,Card,Y
1655,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1655,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1655,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1655,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1656,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1657,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1657,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1658,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1659,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1659,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1659,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1659,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1660,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1661,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1662,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1662,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1662,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1662,4,Yawning,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1663,1,Device adhesion issue,Device issues NEC,Device issues,Prod,N
1663,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1663,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1664,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1665,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1666,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1666,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1666,3,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1667,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1668,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1668,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1668,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1669,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1669,2,Flashback,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
1669,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1669,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1669,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1670,1,Drug withdrawal convulsions,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1670,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1671,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
1671,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1672,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1672,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1673,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1673,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1674,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1675,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1675,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1676,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1677,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
1677,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1677,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1677,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1677,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1678,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1678,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1678,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1678,4,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1678,5,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1678,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1678,7,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1678,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1678,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1678,10,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1678,11,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1679,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1679,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1679,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1679,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1679,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1679,6,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1679,7,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1679,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1679,9,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1679,10,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1679,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1679,12,Headache,Headaches NEC,Headaches,Nerv,N
1679,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1679,14,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1679,15,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1679,16,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1679,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1680,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1680,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1680,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1681,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1681,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1681,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1681,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1682,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1682,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1682,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1682,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1683,1,Drug diversion,Criminal activity,Legal issues,SocCi,N
1683,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1683,3,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1684,1,Azotaemia,Renal failure complications,Renal disorders (excl nephropathies),Renal,N
1684,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1684,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1684,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1685,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1685,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1685,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1686,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1687,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1687,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1687,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1687,4,Headache,Headaches NEC,Headaches,Nerv,N
1687,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1688,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
1688,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1688,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1688,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1688,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1688,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1689,1,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1689,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1690,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1690,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1690,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1691,1,Aspartate aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1692,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
1692,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1692,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1692,4,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1692,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1692,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1693,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1693,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1693,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1693,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1693,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1693,6,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1693,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1693,8,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
1693,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1693,10,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1693,11,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1694,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
1694,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1694,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1694,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1694,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1694,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1694,7,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
1694,8,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1695,1,Secondary hypogonadism,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1696,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1697,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1698,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1698,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1698,3,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1698,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1698,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1698,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1698,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1699,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1699,2,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1699,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1699,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1699,5,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1699,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1699,7,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1699,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1699,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1699,10,Headache,Headaches NEC,Headaches,Nerv,N
1699,11,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1699,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1699,13,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1699,14,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1699,15,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
1699,16,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1699,17,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1700,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1701,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1701,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1702,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1702,2,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
1703,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1703,2,Perinatal brain damage,Neonatal disorders due to birth trauma (excl intracranial haemorrhages),Neonatal and perinatal conditions,Preg,N
1704,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1705,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1705,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1705,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1705,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1705,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1705,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1705,7,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1705,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1705,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1706,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1706,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1706,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1706,4,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1706,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1706,6,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
1706,7,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1706,8,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1707,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
1707,2,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1708,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1708,2,Headache,Headaches NEC,Headaches,Nerv,N
1708,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1708,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1709,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1710,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
1710,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1711,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1711,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1711,3,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1712,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1712,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1712,3,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1712,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1712,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1713,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1713,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1713,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1713,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1713,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1713,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1714,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1714,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1715,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1715,2,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1715,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1715,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1715,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1715,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1715,7,Headache,Headaches NEC,Headaches,Nerv,N
1715,8,Headache,Headaches NEC,Headaches,Nerv,N
1715,9,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1715,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1716,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1716,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1716,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1717,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1717,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1718,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1719,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1720,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1720,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1720,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1720,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1721,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1722,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1723,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1723,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1724,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1724,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1724,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1725,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1726,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1726,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1727,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1727,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1727,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1728,1,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1729,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1729,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1730,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1730,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1730,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1731,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1732,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1733,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1734,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1734,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1734,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1734,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1734,5,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1735,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1735,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1735,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1735,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1735,5,Impaired driving ability,Disability issues,Lifestyle issues,SocCi,N
1735,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1735,7,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1735,8,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1735,9,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1735,10,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1735,11,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1736,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1736,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1737,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1737,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1738,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1738,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1738,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1738,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1739,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1740,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1741,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1741,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1741,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1742,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1743,1,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1743,2,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
1744,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1745,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1746,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1746,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1746,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1747,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1748,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1748,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1748,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1749,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1750,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1750,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1751,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1752,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1752,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1752,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1753,1,Hand deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1753,2,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1754,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1754,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1755,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1755,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1756,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1756,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1757,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1757,2,Ovarian mass,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
1757,3,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1757,4,Saliva altered,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1758,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1758,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1758,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1759,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
1760,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1760,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1761,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1762,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1763,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1763,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
1763,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1763,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1764,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1764,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1765,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1765,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1765,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1766,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1766,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1766,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1766,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1766,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1767,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1767,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1768,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1768,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1768,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1768,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1768,5,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1768,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1768,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1769,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1769,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1769,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1769,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1769,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1770,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1770,2,Application site haematoma,Application site reactions,Administration site reactions,Genrl,N
1770,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1770,4,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1770,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1770,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1771,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1771,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1771,3,Upper respiratory tract congestion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1772,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1772,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1773,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1774,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1774,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1774,3,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1774,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1774,5,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1774,6,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1774,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1774,8,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1774,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1775,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1775,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1775,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1775,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1775,5,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1775,6,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1775,7,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1775,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1775,9,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
1775,10,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1775,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1775,12,Myalgia,Muscle pains,Muscle disorders,Musc,N
1775,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1775,14,Tendon pain,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1775,15,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1775,16,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1776,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1776,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1776,3,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1776,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1776,5,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1776,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1776,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1776,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1777,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1777,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1778,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1778,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1779,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1779,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1780,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1781,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1781,2,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1781,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1781,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1782,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1782,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1782,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1782,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1782,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1782,6,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1782,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1782,8,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1782,9,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1783,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1783,2,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1784,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1785,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1785,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1786,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1787,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1788,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
1788,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1788,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1789,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1790,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1790,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
1791,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1792,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1792,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1792,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1793,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1794,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1794,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1794,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1795,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1795,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1795,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1795,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1795,5,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1796,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1796,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
1796,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1797,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1797,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1797,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1797,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1798,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
1798,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
1798,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1798,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1798,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1799,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1799,2,Headache,Headaches NEC,Headaches,Nerv,N
1799,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
1799,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1800,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1800,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1801,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1801,2,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
1801,3,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1802,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1802,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1803,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1804,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1804,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1805,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1805,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1806,1,Adjustment disorder with depressed mood,Adjustment disorders,Adjustment disorders (incl subtypes),Psych,N
1807,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1808,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1809,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1809,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1810,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1810,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1811,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1812,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1813,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1814,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1815,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1815,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1815,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1816,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1817,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1818,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1819,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1820,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1821,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1822,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1823,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
1823,2,Ligament pain,Ligament disorders,"Tendon, ligament and cartilage disorders",Musc,N
1823,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1823,4,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
1824,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1824,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1825,1,Homicide,Criminal activity,Legal issues,SocCi,N
1826,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1826,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1826,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1827,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1827,2,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,Y
1827,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1827,4,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1827,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1827,6,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1828,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1828,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1829,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1829,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1829,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1830,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1830,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1830,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1830,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1831,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1831,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1831,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1832,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1832,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1833,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1833,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1833,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1834,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1834,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1834,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1834,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1834,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1835,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1836,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1837,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1838,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1839,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1840,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1840,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1841,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1842,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1842,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1842,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1842,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1842,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1843,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1843,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1843,3,Application site scar,Application site reactions,Administration site reactions,Genrl,N
1843,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1844,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1844,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1844,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1844,4,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1844,5,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,Y
1844,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1844,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1844,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1845,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
1845,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1845,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1845,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1846,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1846,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1846,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1847,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1848,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1848,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1848,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1849,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1849,2,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1849,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1850,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
1850,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1850,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1850,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1851,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1851,2,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
1851,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1851,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1852,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1852,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1853,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1853,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1854,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1854,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1855,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1855,2,Application site papules,Application site reactions,Administration site reactions,Genrl,N
1855,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1856,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1857,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1858,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1858,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1858,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1858,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1858,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1858,6,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1859,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1859,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1859,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1860,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1861,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1861,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1862,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
1863,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
1863,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1863,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1864,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1864,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1865,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1865,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1865,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1866,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1866,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1866,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1867,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1868,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1868,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1869,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1870,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1871,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1871,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1872,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1873,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1873,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1873,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1873,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1873,5,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1873,6,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1873,7,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1873,8,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1873,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1873,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1873,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1873,12,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1873,13,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1873,14,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1873,15,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1873,16,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1874,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1874,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1875,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1876,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1876,2,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
1877,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1877,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1878,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1878,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1878,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1879,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1880,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1880,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1881,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1882,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1883,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1883,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1884,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1884,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1884,3,Drug screen positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
1884,4,Drug screen positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
1885,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1885,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1886,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1886,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1886,3,Decreased eye contact,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1886,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1886,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1886,6,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1886,7,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1886,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1886,9,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1886,10,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1886,11,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1886,12,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1886,13,Oxygen saturation abnormal,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1886,14,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1886,15,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1886,16,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1886,17,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1886,18,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1886,19,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1887,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1888,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1888,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1889,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1889,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1889,3,Headache,Headaches NEC,Headaches,Nerv,N
1889,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1889,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1890,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1891,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1892,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1892,2,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1893,1,Burning sensation mucosal,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1894,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1894,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1895,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1895,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1895,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1895,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1895,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1895,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1895,7,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1896,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1896,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1897,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1897,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1897,3,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1897,4,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1898,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
1898,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1899,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1900,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1901,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1902,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1902,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1902,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1903,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1903,2,Pharyngeal hypoaesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1904,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1904,2,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
1904,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1904,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1905,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1905,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1905,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1905,4,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1905,5,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1905,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1906,1,Homicide,Criminal activity,Legal issues,SocCi,N
1906,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1907,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1908,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1908,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1909,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1909,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1910,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1911,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1911,2,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1911,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1911,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1911,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1912,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1912,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1913,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1913,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1914,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1914,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1914,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1915,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1915,2,Headache,Headaches NEC,Headaches,Nerv,N
1915,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1915,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1916,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1916,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1916,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1916,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1917,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1917,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1917,3,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
1918,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1918,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1918,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1919,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1919,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1920,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1921,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1922,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1922,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1922,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1922,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1923,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1923,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1924,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1924,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1924,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1925,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1925,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1925,3,Foetal heart rate abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
1926,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1926,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1927,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1927,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1928,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1928,2,Multiple injuries,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
1928,3,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1929,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1929,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1930,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1930,2,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1930,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1931,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1931,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1932,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
1932,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1933,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1933,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1934,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1934,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1935,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1935,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1936,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1936,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1937,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1938,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1939,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1940,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1940,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1941,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1941,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1941,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1941,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1941,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1942,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1942,2,Spinal deformity,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1942,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1942,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1943,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1943,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1944,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
1945,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1945,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1945,3,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1946,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1946,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1947,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1947,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1947,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1947,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1947,5,Migraine,Migraine headaches,Headaches,Nerv,N
1947,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1947,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1947,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1947,9,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1947,10,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1947,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1948,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1948,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1949,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1949,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1950,1,Amniorrhoea,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1950,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1950,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1951,1,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
1951,2,Cyanosis neonatal,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
1951,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1951,4,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1952,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1952,2,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1952,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1952,4,Neonatal seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1953,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1954,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1954,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1955,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1955,2,Headache,Headaches NEC,Headaches,Nerv,N
1956,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1957,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1957,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1957,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1958,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1958,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1958,3,Headache,Headaches NEC,Headaches,Nerv,N
1958,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1958,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1959,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1959,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
1959,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1959,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1960,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1960,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1960,3,Infantile vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1961,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1961,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1962,1,Headache,Headaches NEC,Headaches,Nerv,N
1963,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1963,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1964,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1965,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1965,2,Pruritus allergic,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1966,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1966,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1967,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1967,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1968,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1968,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1969,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1969,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1970,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1971,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1971,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1972,1,Death neonatal,Death and sudden death,Fatal outcomes,Genrl,Y
1972,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1973,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1973,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1974,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1974,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1975,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1976,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1976,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1977,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1977,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1977,3,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1977,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1978,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1978,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1978,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1978,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1979,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1979,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1980,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1980,2,Drug diversion,Criminal activity,Legal issues,SocCi,N
1980,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1980,4,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1981,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1981,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1982,1,Headache,Headaches NEC,Headaches,Nerv,N
1982,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1983,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1983,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1984,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1984,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1984,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1984,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1984,5,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1985,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1985,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1985,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1985,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1985,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1985,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1985,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1986,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1986,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1986,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1986,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1987,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1987,2,Gestational hypertension,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
1988,1,Agitation neonatal,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1988,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1988,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1988,4,Grimacing,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1988,5,Tremor neonatal,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1989,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1989,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1990,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1991,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1991,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1992,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1992,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1993,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1993,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1993,3,Immobile,Disability issues,Lifestyle issues,SocCi,N
1993,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1994,1,Acne infantile,Acnes,Skin appendage conditions,Skin,N
1994,2,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1994,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1995,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1995,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1995,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1995,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
1995,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1996,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
1996,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1996,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1997,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1997,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1998,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1998,2,Laryngeal dysplasia,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1998,3,Myxoid cyst,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1998,4,Respiratory disorder neonatal,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
1999,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2000,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2000,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
2000,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2001,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2001,2,Hypovitaminosis,Vitamin deficiencies NEC,Vitamin related disorders,Metab,N
2001,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2002,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2002,2,Distractibility,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
2002,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2002,4,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
2003,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2003,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2003,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2003,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2003,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2004,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2004,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2004,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2004,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2005,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2005,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2005,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2006,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2006,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2007,1,Congenital scoliosis,Musculoskeletal and connective tissue disorders of spine congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
2007,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2007,3,Foetal malformation,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
2007,4,Limb reduction defect,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
2007,5,Single functional kidney,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2008,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2008,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2008,3,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2008,4,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2009,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2009,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2009,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2009,4,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2010,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
2010,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2011,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
2011,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
2012,1,Ejaculation disorder,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
2013,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2013,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2014,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2014,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2014,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2015,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2015,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2015,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2016,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2016,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2016,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2017,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2018,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2018,2,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2019,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2019,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2020,1,Acne,Acnes,Skin appendage conditions,Skin,N
2020,2,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2021,1,Headache,Headaches NEC,Headaches,Nerv,N
2022,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2022,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2022,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2022,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2023,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2023,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2023,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2023,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2024,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2024,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2024,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2025,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2026,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
2027,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2028,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2028,2,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2028,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2029,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2029,2,Drug diversion,Criminal activity,Legal issues,SocCi,N
2030,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2030,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2030,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2030,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2031,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2031,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2032,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2032,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2032,3,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2032,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2033,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2033,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2034,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2034,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2034,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2034,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2035,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2035,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2035,3,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2035,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2035,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2035,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2036,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2036,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2036,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2036,4,Oral mucosal eruption,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2036,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2036,6,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2036,7,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2036,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2037,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2038,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2038,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2039,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2039,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2040,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2040,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2040,3,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
2040,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2041,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2041,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2041,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2041,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2042,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2042,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2042,3,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2043,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2043,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2043,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2044,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2044,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2044,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2045,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2046,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2047,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2047,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2048,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2048,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2049,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2050,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2051,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2052,1,Application site scar,Application site reactions,Administration site reactions,Genrl,N
2052,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2053,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2053,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2053,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2054,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2054,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2054,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2054,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2055,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2056,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2057,1,Device adhesion issue,Device issues NEC,Device issues,Prod,N
2057,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2058,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2059,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2060,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2061,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2062,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
2062,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2063,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2063,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
2064,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2065,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
2065,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2065,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2065,4,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
2066,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2066,2,Headache,Headaches NEC,Headaches,Nerv,N
2067,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2068,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2068,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2068,3,Dissociation,Dissociative states,Dissociative disorders,Psych,N
2068,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2068,5,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2068,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2068,7,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2068,8,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2068,9,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2068,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2068,11,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2068,12,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2068,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2068,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2068,15,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2069,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2070,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2070,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2071,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
2071,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2071,3,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2071,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2072,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2072,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2073,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
2073,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2073,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2073,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2073,5,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2074,1,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2074,2,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
2075,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
2075,2,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
2075,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2075,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2075,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2076,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2077,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2078,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2079,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
2079,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2080,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2080,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2080,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2080,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2081,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2082,1,Product deposit,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2082,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2082,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2083,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2084,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2084,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2084,3,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
2085,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
2086,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2087,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2088,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2088,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2088,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2089,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2090,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2091,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2091,2,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
2091,3,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2092,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2092,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2092,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2093,1,Headache,Headaches NEC,Headaches,Nerv,N
2093,2,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2094,1,Burning sensation mucosal,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2095,1,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
2095,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2095,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
2096,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2096,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2097,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2097,2,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
2098,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2099,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2100,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2101,1,Cancer pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
2101,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2102,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2103,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
2103,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2103,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2103,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2103,5,Subileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
2104,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2104,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2105,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2106,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2106,2,Headache,Headaches NEC,Headaches,Nerv,N
2106,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2106,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2106,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2107,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2107,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2107,3,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
2107,4,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2107,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2107,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2107,7,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2107,8,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2107,9,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2107,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2108,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2108,2,Headache,Headaches NEC,Headaches,Nerv,N
2109,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2110,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2110,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2110,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2110,4,Headache,Headaches NEC,Headaches,Nerv,N
2110,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2111,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
2111,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2111,3,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2111,4,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
2111,5,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
2112,1,Chest expansion decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2112,2,Headache,Headaches NEC,Headaches,Nerv,N
2112,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2112,4,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
2112,5,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2113,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
2113,2,Drug diversion,Criminal activity,Legal issues,SocCi,N
2113,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2113,4,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2114,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
2114,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2115,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
2115,2,Device leakage,Device issues NEC,Device issues,Prod,N
2115,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2115,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2116,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
2116,2,Congestive hepatopathy,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
2116,3,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2116,4,Obstructive sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2116,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2117,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2117,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2118,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2119,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
2119,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2119,3,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
2119,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2120,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2120,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2120,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2120,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2120,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2120,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2120,7,Headache,Headaches NEC,Headaches,Nerv,N
2120,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2120,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2120,10,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2120,11,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2120,12,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2120,13,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2120,14,Renal haemorrhage,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2120,15,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2120,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2121,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2121,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2121,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2122,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2123,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
2124,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2124,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2124,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2124,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2124,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
2124,6,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2124,7,Saliva altered,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2124,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2125,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2125,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
2125,3,Device leakage,Device issues NEC,Device issues,Prod,N
2125,4,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2126,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2126,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2126,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2127,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2127,2,Homicide,Criminal activity,Legal issues,SocCi,N
2128,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2128,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2128,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2129,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2129,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2130,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2130,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2130,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2131,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2131,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2132,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2133,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2133,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2134,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2134,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2134,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
2135,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2135,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2136,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2136,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2137,1,Foetal monitoring abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
2137,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2137,3,Prolonged pregnancy,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2138,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2139,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2139,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2139,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2139,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2140,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2140,2,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
2140,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2141,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2141,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2141,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
2141,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2141,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
2141,6,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2141,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2142,1,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
2143,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2143,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2143,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2143,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2144,1,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2144,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2144,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2145,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2146,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2146,2,Device adhesion issue,Device issues NEC,Device issues,Prod,N
2146,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2146,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2146,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2147,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2147,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2148,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2148,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
2149,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2149,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2150,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2150,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2150,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2151,1,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2152,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2152,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2153,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2153,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2153,3,Device adhesion issue,Device issues NEC,Device issues,Prod,N
2154,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2155,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2155,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2155,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2155,4,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2155,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2155,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2156,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2157,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2158,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2159,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2160,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2161,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2161,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2162,1,Application site eczema,Application site reactions,Administration site reactions,Genrl,N
2162,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2163,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2163,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2163,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2163,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2163,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2163,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2164,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2165,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2165,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2166,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2166,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2166,3,Application site scar,Application site reactions,Administration site reactions,Genrl,N
2167,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2168,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2169,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2169,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2170,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2171,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2172,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2173,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2173,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2173,3,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2174,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2174,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2174,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2174,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2175,1,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2176,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2176,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2176,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2176,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2176,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2176,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2176,7,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2176,8,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2176,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2176,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2176,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2177,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2178,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2179,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2179,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2179,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2179,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2179,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2180,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2181,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2181,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2181,3,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2181,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2181,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2182,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2182,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2182,3,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
2182,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2183,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2183,2,Migraine,Migraine headaches,Headaches,Nerv,N
2183,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2183,4,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2183,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2183,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2183,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2184,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2184,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2184,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2184,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2185,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2186,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2186,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2187,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2187,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2187,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2187,4,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2188,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2189,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2190,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
2190,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2190,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2190,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2190,5,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
2191,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2191,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2191,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2192,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2192,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2192,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2192,4,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2192,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2192,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2192,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2192,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2192,9,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2193,1,Administration site swelling,Administration site reactions NEC,Administration site reactions,Genrl,N
2193,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2193,3,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2193,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2194,1,Skin fragility,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2194,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
2195,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
2195,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2195,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2196,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2196,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2196,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
2196,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2196,5,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2197,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2198,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2199,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2199,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2199,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2200,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2200,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2200,3,Headache,Headaches NEC,Headaches,Nerv,N
2200,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2200,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2201,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2201,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2201,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2201,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2202,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2203,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2203,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2204,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
2204,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2204,3,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
2205,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2206,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2207,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2207,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2208,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2209,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2210,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2210,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2211,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2212,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
2212,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2212,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2213,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2214,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2214,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2214,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2215,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2215,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2215,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2216,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2217,1,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
2218,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2218,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2218,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2219,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2219,2,Application site papules,Application site reactions,Administration site reactions,Genrl,N
2219,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2219,4,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2220,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2221,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2221,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2221,3,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2222,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2222,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2223,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2223,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2223,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2223,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2223,5,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2223,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2223,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2223,8,Migraine,Migraine headaches,Headaches,Nerv,N
2223,9,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2223,10,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2223,11,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2223,12,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2224,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2224,2,Migraine,Migraine headaches,Headaches,Nerv,N
2225,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2226,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2226,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2227,1,Application site photosensitivity reaction,Application site reactions,Administration site reactions,Genrl,N
2228,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2229,1,Accidental poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2230,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
2230,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2230,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2230,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2230,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2231,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2232,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2232,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2233,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2233,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2234,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2235,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2235,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2235,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2235,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2236,1,Headache,Headaches NEC,Headaches,Nerv,N
2237,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2237,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2237,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2238,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2239,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2240,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2240,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2240,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2241,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2241,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2242,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2242,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2242,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2243,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2244,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2245,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2246,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2247,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2248,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2248,2,"Hallucination, tactile",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2248,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2248,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2248,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
2248,6,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2248,7,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2249,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2249,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2250,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2250,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2250,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2250,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2250,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2251,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2251,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2252,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2252,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2252,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2252,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2253,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2254,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2254,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2254,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2254,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2254,5,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2255,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2255,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2255,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2256,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2256,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2256,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2256,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2256,5,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2257,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2258,1,Drug screen positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
2258,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2258,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2259,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2260,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2260,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2261,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2261,2,Anhedonia,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2261,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2261,4,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
2261,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2261,6,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2261,7,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2261,8,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2261,9,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2261,10,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2261,11,Drug withdrawal headache,Headaches NEC,Headaches,Nerv,N
2261,12,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2261,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2261,14,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
2261,15,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2261,16,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2261,17,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2261,18,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2261,19,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2261,20,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2261,21,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2261,22,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2261,23,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2261,24,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2261,25,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2262,1,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2263,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2264,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
2264,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2264,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
2264,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2264,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2265,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2266,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2267,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2267,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2268,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2268,2,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2268,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2268,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2268,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2268,6,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2268,7,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
2268,8,"Hallucination, tactile",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2268,9,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2268,10,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2269,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2269,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2269,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2270,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2270,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2271,1,Application site urticaria,Application site reactions,Administration site reactions,Genrl,N
2272,1,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2273,1,Migraine,Migraine headaches,Headaches,Nerv,N
2273,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2273,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2274,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
2274,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2275,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2276,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2276,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2276,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2276,4,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2276,5,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2276,6,Gastrointestinal sounds abnormal,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
2276,7,Headache,Headaches NEC,Headaches,Nerv,N
2276,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2276,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2276,10,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2276,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2277,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2277,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2277,3,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
2278,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2279,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2279,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2280,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2280,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2281,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2281,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2282,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2282,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2283,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2284,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2284,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2284,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2284,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2284,5,Irregular breathing,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2284,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2284,7,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2285,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2285,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2286,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2286,2,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2286,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2287,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2287,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2288,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2288,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
2288,3,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2288,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2288,5,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2288,6,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2288,7,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2289,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2289,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2290,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2290,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2290,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2290,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2290,5,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
2290,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2290,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2291,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2292,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2292,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2292,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2293,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2294,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2294,2,Bedridden,Disability issues,Lifestyle issues,SocCi,N
2294,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2294,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2294,5,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2294,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2295,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2295,2,Oral papule,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
2296,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2296,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2296,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2297,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2297,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2298,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2299,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2299,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2299,3,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2299,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2300,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2300,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2300,3,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2301,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2302,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2303,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2303,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2303,3,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2303,4,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2303,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2304,1,Headache,Headaches NEC,Headaches,Nerv,N
2305,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2306,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2306,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2307,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
2307,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2307,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
2307,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2307,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2308,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
2308,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2308,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
2308,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2308,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2308,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2309,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2310,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2310,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2310,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2310,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2310,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2310,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2311,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2311,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2312,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2312,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2313,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2314,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2315,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2316,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2317,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2318,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2318,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2318,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2319,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2320,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2321,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2321,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2321,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2321,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2322,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2322,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2323,1,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2323,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2323,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2324,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2324,2,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2325,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2326,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2327,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2327,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2328,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2329,1,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2329,2,Alcohol detoxification,Drug withdrawal therapies,Therapeutic procedures and supportive care NEC,Surg,N
2329,3,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2329,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2330,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2330,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2331,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2331,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2331,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2332,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2333,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2333,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2334,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2334,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2335,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
2335,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2335,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2335,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2335,5,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2336,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2336,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2336,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2336,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2336,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2336,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2337,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2337,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2337,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2337,4,Foaming at mouth,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2337,5,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2337,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2337,7,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2337,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2337,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2338,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2338,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2339,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2339,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2339,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2339,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2340,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2340,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2340,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2340,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2340,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2341,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2341,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2341,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2341,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2341,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2341,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2342,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2342,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2343,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
2344,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2344,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2344,3,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2344,4,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
2344,5,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
2345,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2345,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
2346,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2346,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2346,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2346,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2346,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2346,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2346,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2347,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2347,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2348,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2349,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2350,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2350,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2350,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2351,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2351,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2351,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2352,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2353,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2353,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2354,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2355,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2355,2,Dermatitis infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2355,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2356,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2356,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2357,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2357,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2358,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2359,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2359,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2360,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2361,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2361,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2362,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
2362,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2362,3,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2362,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2362,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2362,6,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2363,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2363,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2363,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2363,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2364,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2364,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2365,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2365,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2365,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2365,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2365,5,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2366,1,Administration site discharge,Administration site reactions NEC,Administration site reactions,Genrl,N
2366,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2366,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2367,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2367,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2367,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2367,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2368,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2368,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2369,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2370,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
2370,2,Drug titration error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2370,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2370,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2370,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2370,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2371,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2371,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
2372,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2372,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
2372,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2373,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2374,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2375,1,Chromatopsia,Visual colour distortions,Vision disorders,Eye,N
2376,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2376,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2377,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2377,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2378,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2378,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2378,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2378,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2379,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
2379,2,Application site laceration,Application site reactions,Administration site reactions,Genrl,N
2379,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2380,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2381,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2381,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2381,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2382,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2382,2,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
2382,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2382,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2383,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2384,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2385,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2385,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2385,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2386,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
2387,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
2387,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2388,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2388,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2388,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2388,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2388,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2389,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2389,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2390,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2390,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2391,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2391,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2392,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2392,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2393,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2393,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2394,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2394,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2395,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
2395,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2395,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2395,4,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2395,5,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
2395,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2395,7,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2395,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2395,9,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2396,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2396,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2397,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2397,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2398,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2398,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2399,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2399,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2400,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2401,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2401,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2402,1,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
2402,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2403,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2403,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2403,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2404,1,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2404,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2405,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2406,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2406,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2406,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2407,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
2407,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2407,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2407,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2408,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2408,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2409,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2410,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2410,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2410,3,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
2411,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2411,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2412,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2412,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2412,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2412,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2412,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2413,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2413,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2414,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2414,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2414,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2415,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2415,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2415,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2416,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2416,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2416,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2417,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2418,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2418,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2418,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2418,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2418,5,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2418,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2419,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2419,2,Headache,Headaches NEC,Headaches,Nerv,N
2419,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2419,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2419,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2420,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2420,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2420,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2420,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2421,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2421,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2422,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2422,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2423,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2423,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2424,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2424,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2425,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2426,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2426,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2426,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2427,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2428,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2429,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2429,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2429,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2430,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2430,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2430,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2431,1,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2431,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2431,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2432,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2432,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2432,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2432,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2433,1,17 ketosteroids urine abnormal,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
2433,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2433,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2434,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2434,2,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2435,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2435,2,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2435,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2435,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2435,5,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2436,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2436,2,Headache,Headaches NEC,Headaches,Nerv,N
2436,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2437,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2437,2,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2438,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2438,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2439,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2440,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2440,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2440,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2440,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2441,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2441,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2441,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2441,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2441,5,Headache,Headaches NEC,Headaches,Nerv,N
2441,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2442,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2442,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2442,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2443,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2443,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2443,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2444,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2445,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2445,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2445,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2445,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2446,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2447,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2447,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2447,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2448,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2449,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2449,2,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
2449,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2449,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2449,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2450,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2450,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2450,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2450,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2451,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2451,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2451,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2451,4,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2451,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2451,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
2451,7,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2452,1,Administration site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
2452,2,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
2452,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2453,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
2454,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2454,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2454,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2454,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2454,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2455,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2455,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2455,3,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2456,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2457,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2457,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2457,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2457,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2457,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2458,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2458,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2459,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2460,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2460,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2461,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2461,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2462,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2462,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2462,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2462,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2462,5,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2462,6,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
2462,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2463,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2464,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2464,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2465,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2465,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2465,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2465,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2465,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2466,1,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2466,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2466,3,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2467,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2467,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2468,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2468,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2468,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2468,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2469,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2469,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2469,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2469,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2470,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2470,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2470,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2470,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2471,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2471,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2471,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2471,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2471,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2472,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2473,1,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
2473,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2473,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2473,4,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2473,5,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2473,6,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2473,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2473,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2473,9,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2473,10,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2474,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2475,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2475,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2475,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2476,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2476,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2476,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2477,1,Drug screen false positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
2478,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2478,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2478,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2478,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2478,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2479,1,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
2479,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2480,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
2480,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2481,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2481,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2481,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2481,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2481,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2482,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2482,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2482,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2482,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2482,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2483,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2484,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2484,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2484,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2484,4,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2484,5,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2484,6,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
2484,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2484,8,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2484,9,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2484,10,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2484,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2484,12,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2484,13,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2484,14,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2484,15,Prostatomegaly,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
2484,16,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2484,17,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2485,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2485,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2486,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2486,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2487,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2487,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2487,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2488,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2488,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2488,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2488,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2488,5,Dermal absorption increased,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2489,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2490,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2490,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2490,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2491,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
2491,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2492,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2493,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2494,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2495,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2495,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2495,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2496,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
2496,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2496,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2496,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2497,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2497,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2498,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2499,1,Headache,Headaches NEC,Headaches,Nerv,N
2499,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2500,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2500,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2500,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2500,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2500,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2501,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2502,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2502,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2502,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2502,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2502,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2502,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2503,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2503,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2503,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2503,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2504,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2505,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2506,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2506,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
2507,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
2507,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2508,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2508,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2508,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2508,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2509,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
2509,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2509,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2510,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2511,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2511,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2511,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2511,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2512,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2512,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2512,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2513,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2513,2,Device leakage,Device issues NEC,Device issues,Prod,N
2513,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2514,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2514,2,Application site odour,Application site reactions,Administration site reactions,Genrl,N
2514,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2514,4,Application site papules,Application site reactions,Administration site reactions,Genrl,N
2514,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2514,6,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2514,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2515,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2515,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2515,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2515,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2515,5,Headache,Headaches NEC,Headaches,Nerv,N
2515,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2515,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2515,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2516,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2516,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2516,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2517,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2517,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2517,3,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2517,4,Gastric perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2517,5,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2517,6,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2517,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2517,8,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
2517,9,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2517,10,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2517,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2518,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
2519,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2520,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2521,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2521,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2521,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2521,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2521,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2522,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2522,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2523,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2523,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2523,3,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
2523,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2524,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2524,2,Asocial behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2524,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2524,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2524,5,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2524,6,Hyperphagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2524,7,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2524,8,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2524,9,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2524,10,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2524,11,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2524,12,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2525,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2525,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2526,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2526,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2527,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2528,1,Application site photosensitivity reaction,Application site reactions,Administration site reactions,Genrl,N
2528,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
2529,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2530,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2530,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2530,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2531,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2531,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2532,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2533,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2533,2,Application site scar,Application site reactions,Administration site reactions,Genrl,N
2534,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2534,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2534,3,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2535,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2536,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2537,1,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
2537,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2538,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2539,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2540,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2541,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2541,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2541,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2541,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2542,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2543,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2544,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2544,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2544,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2545,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2546,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2546,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2546,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2546,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2546,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2546,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2546,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2546,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2546,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2546,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2547,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2547,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2547,3,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2547,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2547,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2548,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2549,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2549,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2549,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2549,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2549,5,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2550,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2551,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2552,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2552,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2553,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2554,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2554,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2554,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2554,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2555,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2555,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2556,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2556,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2556,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2556,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2556,5,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2556,6,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
2556,7,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2556,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2556,9,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2557,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2557,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2558,1,Application site wound,Application site reactions,Administration site reactions,Genrl,N
2558,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2558,3,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
2559,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2559,2,Accidental poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2559,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2559,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2559,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2559,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
2560,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2560,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2560,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2560,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
2560,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2561,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
2561,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2561,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2562,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2562,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2562,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2563,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2563,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2564,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2564,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2564,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2564,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2564,5,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
2564,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2565,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2565,2,Headache,Headaches NEC,Headaches,Nerv,N
2565,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2565,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2565,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2565,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2566,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2566,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
2566,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2566,4,Dissociation,Dissociative states,Dissociative disorders,Psych,N
2566,5,Drug diversion,Criminal activity,Legal issues,SocCi,N
2566,6,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2566,7,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2566,8,Headache,Headaches NEC,Headaches,Nerv,N
2566,9,Snoring,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2566,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2567,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,Y
2567,2,Impaired driving ability,Disability issues,Lifestyle issues,SocCi,N
2567,3,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2568,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2568,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2569,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2569,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2569,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2569,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2569,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2570,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2570,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2570,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2570,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2571,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2571,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2572,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
2573,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2573,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2574,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2574,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2575,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2575,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2576,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2576,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2576,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2577,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2577,2,Limb deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2577,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2578,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2579,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
2579,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2580,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2581,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2581,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2582,1,Headache,Headaches NEC,Headaches,Nerv,N
2583,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2583,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2584,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2584,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2584,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2585,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2585,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2586,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2587,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2588,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
2589,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2590,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2590,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2590,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2590,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2590,5,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
2590,6,Migraine,Migraine headaches,Headaches,Nerv,N
2590,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2590,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2590,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2590,10,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2590,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2590,12,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2590,13,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2590,14,Vomiting projectile,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2591,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2592,1,Migraine,Migraine headaches,Headaches,Nerv,N
2592,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2592,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2592,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2593,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2594,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2594,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2594,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2595,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2595,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2596,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2596,2,Anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
2596,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2596,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2596,5,Headache,Headaches NEC,Headaches,Nerv,N
2596,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2596,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2596,8,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2596,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2596,10,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
2596,11,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2597,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2597,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2597,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2597,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2598,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
2598,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2599,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2599,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2599,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2599,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2599,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2600,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2600,2,Headache,Headaches NEC,Headaches,Nerv,N
2600,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2600,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2601,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2601,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2601,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2601,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2602,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2602,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2602,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2603,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2603,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2604,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2604,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2605,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
2605,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2605,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2605,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2605,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2605,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2605,7,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2606,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2606,2,Headache,Headaches NEC,Headaches,Nerv,N
2607,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2607,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2607,3,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2607,4,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
2607,5,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
2607,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2607,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2608,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2609,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2609,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2610,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
2610,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2611,1,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
2612,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2612,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2612,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2612,4,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2612,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2613,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2614,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2615,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2616,1,Migraine,Migraine headaches,Headaches,Nerv,N
2616,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2616,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2617,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2617,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2617,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2617,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2617,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2618,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2619,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2619,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2619,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2620,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2620,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2621,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2621,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2622,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2623,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2624,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2624,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2625,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2625,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2626,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2627,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2627,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2627,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2627,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2628,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2628,2,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2628,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2628,4,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2629,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2629,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2629,3,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
2630,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2630,2,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2630,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2631,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2632,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2632,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2632,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2633,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2633,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2634,1,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
2634,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2634,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2635,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2635,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2635,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2636,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2636,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2636,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2636,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2637,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2638,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2639,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2640,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2641,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2641,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2641,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2641,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2641,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2641,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2641,7,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2642,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2642,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2642,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2643,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2643,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2643,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2644,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2644,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2645,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2645,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2645,3,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2646,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2647,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2648,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2649,1,Migraine,Migraine headaches,Headaches,Nerv,N
2650,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2650,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
2650,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2651,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2651,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2651,3,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
2652,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2653,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2653,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2654,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2655,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2655,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2656,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
2656,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2656,3,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2657,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2657,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2657,3,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2657,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2657,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2658,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2658,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2658,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2659,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2659,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2659,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2659,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2660,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2660,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2661,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2661,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2662,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2662,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2663,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2664,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2664,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2665,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2665,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2665,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2665,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2665,5,Tongue pruritus,Tongue signs and symptoms,Tongue conditions,Gastr,N
2666,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2666,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2666,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2666,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2666,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
2666,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2666,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2667,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
2667,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2667,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2668,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2669,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
2669,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2670,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2671,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2671,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2671,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2671,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2671,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2671,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2672,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2673,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2673,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2673,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2673,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2674,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2674,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2675,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2675,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2676,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2676,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2676,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2676,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2676,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2677,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2677,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2677,3,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
2677,4,Device leakage,Device issues NEC,Device issues,Prod,N
2677,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2678,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2678,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2678,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2678,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2678,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2678,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2679,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
2679,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2679,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2680,1,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2680,2,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2681,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2682,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2682,2,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
2682,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2682,4,Migraine,Migraine headaches,Headaches,Nerv,N
2682,5,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2682,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2683,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2683,2,Compulsions,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
2683,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2683,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2683,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2684,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2684,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2684,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2684,4,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
2685,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2685,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2686,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2686,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2687,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2687,2,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2688,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2688,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2688,3,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
2688,4,Application site scab,Application site reactions,Administration site reactions,Genrl,N
2688,5,Device leakage,Device issues NEC,Device issues,Prod,N
2688,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2688,7,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2688,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2688,9,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2689,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2689,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2690,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2690,2,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2690,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2690,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2690,5,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2691,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2692,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2692,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2692,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2693,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2693,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2693,3,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2693,4,Oral pustule,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2693,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2693,6,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
2694,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2695,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2695,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2695,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2696,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2696,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2697,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
2697,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2697,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2698,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2698,2,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2698,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2699,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2700,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2700,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2700,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2701,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2702,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2702,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2703,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2704,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2704,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2704,3,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2704,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2704,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2705,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2705,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2706,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2707,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2708,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2708,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2708,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2708,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2709,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2709,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2709,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2709,4,Headache,Headaches NEC,Headaches,Nerv,N
2710,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2711,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2711,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2712,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2712,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2712,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2712,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2713,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2713,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2713,3,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2714,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2715,1,Product solubility abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2715,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2716,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2716,2,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
2716,3,Oropharyngeal plaque,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2717,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2717,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2718,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2718,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2718,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2719,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2720,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2721,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2722,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2722,2,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
2722,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2723,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2723,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2723,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2724,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2724,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2724,3,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2724,4,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
2724,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2724,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
2725,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2725,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2725,3,Product blister packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2725,4,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2725,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2726,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2726,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2727,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2727,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2728,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2729,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2729,2,Headache,Headaches NEC,Headaches,Nerv,N
2730,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2730,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2731,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2732,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2732,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2732,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2732,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2732,5,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
2732,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2732,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2733,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2733,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2733,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2734,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2734,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2734,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2735,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2735,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2735,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2735,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2735,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2735,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2735,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2735,8,Headache,Headaches NEC,Headaches,Nerv,N
2735,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2735,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2735,11,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2736,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2737,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2737,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2738,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2738,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2738,3,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2738,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2738,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2738,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2739,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
2739,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2739,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2739,4,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
2740,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2740,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2740,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2740,4,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
2741,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2741,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2741,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2742,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2742,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2743,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2743,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2744,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2744,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
2744,3,Sensory overload,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2745,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2745,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2745,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2745,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2745,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2746,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2746,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2747,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2747,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2748,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2749,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2749,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2749,3,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2750,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2750,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2751,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2751,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2751,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2752,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2752,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2752,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2752,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
2752,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2753,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2754,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2754,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2754,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2754,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2754,5,Daydreaming,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
2754,6,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2754,7,Physical disability,Disability issues,Lifestyle issues,SocCi,N
2754,8,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2754,9,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2755,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2756,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2756,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2756,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2756,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2757,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2757,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2757,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2757,4,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
2758,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2758,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2758,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2758,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2758,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2759,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2759,2,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
2759,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2759,4,Burns third degree,Thermal burns,Injuries by physical agents,Inj&P,N
2759,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2759,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2760,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2761,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2762,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2762,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2763,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2763,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2763,3,Plicated tongue,Tongue disorders,Tongue conditions,Gastr,N
2764,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2765,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2766,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2767,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2768,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2768,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2769,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2769,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2769,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2769,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2770,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2771,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2772,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2772,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
2772,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2773,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2773,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2773,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2774,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2775,1,Product solubility abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2775,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2776,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2777,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2778,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2779,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2780,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2780,2,Dermal absorption impaired,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2780,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2781,1,Cutaneous symptom,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
2782,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2782,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2782,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
2782,4,Sensory overload,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2783,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2783,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2784,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2784,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2784,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2785,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2786,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2786,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2787,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2788,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2788,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2788,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2789,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2789,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2789,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2790,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2791,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2791,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2791,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2792,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2792,2,Headache,Headaches NEC,Headaches,Nerv,N
2792,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2793,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2793,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2793,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2793,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2794,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2795,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2795,2,Headache,Headaches NEC,Headaches,Nerv,N
2795,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2795,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2796,1,Application site acne,Application site reactions,Administration site reactions,Genrl,N
2796,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2796,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2796,4,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2796,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2797,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2797,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2798,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2799,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2799,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2800,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2800,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2800,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2800,4,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2800,5,Migraine,Migraine headaches,Headaches,Nerv,N
2801,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
2801,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2802,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2802,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2803,1,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2803,2,Piloerection,Pilar disorders NEC,Skin appendage conditions,Skin,N
2803,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
2803,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2804,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2805,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2805,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2806,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2806,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2807,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2807,2,Decreased eye contact,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2807,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2807,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2807,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2807,6,Headache,Headaches NEC,Headaches,Nerv,N
2807,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2807,8,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2807,9,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
2807,10,Osmophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
2807,11,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2807,12,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2807,13,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2807,14,Phonophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
2807,15,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2807,16,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2807,17,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2807,18,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2807,19,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2807,20,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2808,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2808,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2809,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2809,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2809,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2810,1,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
2811,1,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
2812,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2812,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2812,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2812,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2813,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2813,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2813,3,Headache,Headaches NEC,Headaches,Nerv,N
2813,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2813,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2813,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2814,1,Derealisation,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
2814,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2814,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2814,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2814,5,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2814,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2814,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2814,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2815,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2816,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2816,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2816,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2817,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2817,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2817,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2818,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2819,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2820,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2820,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2820,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2820,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2821,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2821,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2821,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2822,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2823,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2823,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2823,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2823,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2824,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2824,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2824,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2824,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2825,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2825,2,Headache,Headaches NEC,Headaches,Nerv,N
2825,3,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2825,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2826,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2827,1,Headache,Headaches NEC,Headaches,Nerv,N
2828,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2828,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2829,1,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
2829,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2829,3,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
2829,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2829,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2829,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2830,1,Headache,Headaches NEC,Headaches,Nerv,N
2830,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2831,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2831,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2832,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2832,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2832,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2832,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2832,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2832,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2832,7,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
2833,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2833,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2834,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2834,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2834,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2835,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2835,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2836,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2836,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2836,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2836,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2837,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2837,2,Body height decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2837,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2837,4,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2837,5,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2837,6,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
2837,7,Headache,Headaches NEC,Headaches,Nerv,N
2837,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2837,9,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
2837,10,Migraine,Migraine headaches,Headaches,Nerv,N
2837,11,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2837,12,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
2837,13,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2838,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2838,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2839,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2840,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2840,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2840,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2841,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2842,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2843,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2843,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2844,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2845,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2846,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
2846,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2846,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2846,4,Application site plaque,Application site reactions,Administration site reactions,Genrl,N
2846,5,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2846,6,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2847,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2847,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2848,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2848,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2848,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2848,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2848,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2849,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2849,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2849,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2850,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2850,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2851,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2851,2,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
2852,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2853,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2853,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2853,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
2853,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2853,5,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
2854,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2854,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2855,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2855,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2855,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2855,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
2855,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2856,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
2856,2,Device leakage,Device issues NEC,Device issues,Prod,N
2857,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2858,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2859,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2859,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2859,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2860,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2860,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2860,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2860,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2860,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2860,6,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2860,7,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2860,8,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2860,9,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2860,10,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2860,11,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2860,12,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2860,13,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
2860,14,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2860,15,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2860,16,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2860,17,Post-traumatic stress disorder,Stress disorders,Anxiety disorders and symptoms,Psych,N
2860,18,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2860,19,Tongue fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2861,1,Axillary mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2862,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
2862,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2863,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2863,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2863,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2863,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2864,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2864,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2864,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2864,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2864,5,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,Y
2864,6,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
2864,7,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2864,8,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2864,9,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2864,10,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2864,11,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2864,12,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2864,13,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2864,14,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2864,15,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2864,16,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
2864,17,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2864,18,Myalgia,Muscle pains,Muscle disorders,Musc,N
2864,19,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2864,20,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2864,21,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2864,22,Stereotypy,Stereotypies and automatisms,Changes in physical activity,Psych,N
2864,23,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2864,24,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2865,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2865,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2865,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2865,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2866,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2866,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2867,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2867,2,Salivary hyposecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2868,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2868,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2868,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2868,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2868,5,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2868,6,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2869,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2869,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2869,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2869,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2870,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2870,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2871,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2872,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2873,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2874,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2874,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2874,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2875,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2875,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2875,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2875,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2875,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2876,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2877,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2877,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2877,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2877,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2878,1,Administration site reaction,Administration site reactions NEC,Administration site reactions,Genrl,N
2878,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2879,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2879,2,Injection site scab,Injection site reactions,Administration site reactions,Genrl,N
2880,1,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2880,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2881,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2881,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2882,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2883,1,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
2883,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2884,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2884,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2885,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2885,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2885,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2885,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2885,5,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2885,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2886,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2887,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2887,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2888,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2888,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2888,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2889,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2889,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2890,1,Dental discomfort,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
2891,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2892,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2892,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2893,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2893,2,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
2893,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2893,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2893,5,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2893,6,Dumping syndrome,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2893,7,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2894,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2894,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2894,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2895,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2895,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2896,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2897,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2898,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2898,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2898,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2898,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2899,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
2900,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2901,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2902,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2903,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2903,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2903,3,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
2903,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2903,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2904,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2904,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2904,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2904,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2905,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2905,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2906,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2906,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2906,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2907,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2907,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2907,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2907,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2908,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2908,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2909,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2910,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2910,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2911,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2912,1,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
2913,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2914,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2914,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2914,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2915,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2915,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2916,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2916,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2916,3,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2916,4,Respiratory tract irritation,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2917,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2917,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2917,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2917,4,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2917,5,Urinary hesitation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2917,6,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2918,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
2919,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2919,2,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2919,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2919,4,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2919,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2920,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2921,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2921,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2921,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2921,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2922,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2922,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2922,3,Sluggishness,Asthenic conditions,General system disorders NEC,Genrl,N
2923,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2924,1,Headache,Headaches NEC,Headaches,Nerv,N
2924,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2924,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2924,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2925,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2925,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2926,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2927,1,Headache,Headaches NEC,Headaches,Nerv,N
2928,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2928,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2929,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2929,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2930,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2930,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2931,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2932,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2932,2,Migraine,Migraine headaches,Headaches,Nerv,N
2932,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2933,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2933,2,Headache,Headaches NEC,Headaches,Nerv,N
2933,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2934,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2934,2,Headache,Headaches NEC,Headaches,Nerv,N
2934,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2935,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2936,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2937,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2937,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2938,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2939,1,Male sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
2940,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2941,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2942,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2942,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2942,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2943,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2944,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2944,2,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2945,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2945,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2945,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2945,4,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2946,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2947,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2947,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2948,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2948,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2948,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2949,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2949,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2949,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2949,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2949,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2950,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2950,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2950,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2950,4,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2951,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2951,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2951,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2951,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2952,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
2953,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
2953,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
2953,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2953,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2954,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2955,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2955,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2955,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2955,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2956,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2956,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2956,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2956,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2956,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2957,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2957,2,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
2957,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2957,4,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2958,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2958,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2958,3,Injection site muscle weakness,Injection site reactions,Administration site reactions,Genrl,N
2958,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2958,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2959,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2959,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2959,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2960,1,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
2960,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
2961,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2961,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2961,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2961,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2961,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2962,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2962,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2963,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2964,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2965,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2965,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2965,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2965,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2966,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2966,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2966,3,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2966,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2966,5,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2967,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2968,1,Drug diversion,Criminal activity,Legal issues,SocCi,N
2968,2,Drug diversion,Criminal activity,Legal issues,SocCi,N
2968,3,Drug diversion,Criminal activity,Legal issues,SocCi,N
2969,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2970,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2970,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2970,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
2971,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2971,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2971,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2971,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2971,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2971,6,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2971,7,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
2971,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2971,9,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2972,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2972,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2973,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2973,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2974,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2974,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2975,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2975,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2976,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2976,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2977,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2977,2,Headache,Headaches NEC,Headaches,Nerv,N
2978,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
2978,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2978,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2978,4,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
2978,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2978,6,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2978,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2978,8,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2978,9,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2979,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2980,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2980,2,Eating disorder symptom,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2980,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2980,4,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2981,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
2981,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2981,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2982,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2982,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2982,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2982,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2982,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2982,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2983,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2983,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2983,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2983,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2983,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2983,6,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2983,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2983,8,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
2983,9,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2984,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2984,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2985,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2985,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2985,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2985,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2985,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2985,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2985,7,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2985,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2985,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2985,10,Headache,Headaches NEC,Headaches,Nerv,N
2985,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2985,12,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2985,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2985,14,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2985,15,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2986,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2986,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2987,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2987,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2988,1,Administration site ulcer,Administration site reactions NEC,Administration site reactions,Genrl,N
2988,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2989,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2989,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2989,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2989,4,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
2989,5,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2989,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2990,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2990,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2991,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2991,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2991,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2992,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2992,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2992,3,Headache,Headaches NEC,Headaches,Nerv,N
2993,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2994,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2995,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2995,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2995,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2995,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2995,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2995,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2995,7,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2995,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2995,9,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2995,10,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2995,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2995,12,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2995,13,Headache,Headaches NEC,Headaches,Nerv,N
2995,14,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2995,15,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2995,16,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2995,17,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2995,18,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2995,19,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2995,20,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2995,21,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2995,22,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2995,23,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2996,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2996,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2996,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2996,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2997,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2998,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2999,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2999,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3000,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3000,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3001,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3001,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3002,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3002,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3003,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3004,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3005,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3006,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3007,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3007,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3007,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3008,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3009,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3009,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3009,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3009,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3009,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3010,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3010,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3011,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3012,1,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3012,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
3012,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3013,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3013,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3013,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3014,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3015,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3015,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3015,3,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3015,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3016,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3016,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3017,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3018,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3019,1,Drug detoxification,Drug withdrawal therapies,Therapeutic procedures and supportive care NEC,Surg,N
3019,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3019,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3019,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3020,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3020,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3021,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3021,2,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3021,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3021,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3022,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3022,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3022,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3023,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3023,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3023,3,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3023,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3023,5,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3023,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3024,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3025,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3025,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
3025,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3025,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
3026,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3027,1,Alcohol poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3027,2,Death,Death and sudden death,Fatal outcomes,Genrl,N
3027,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3028,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3029,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3029,2,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3029,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3029,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3030,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3031,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3031,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3032,1,Migraine,Migraine headaches,Headaches,Nerv,N
3032,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3033,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
3033,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
3033,3,Oral administration complication,Administration site reactions NEC,Administration site reactions,Genrl,N
3033,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3033,5,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3033,6,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3033,7,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3034,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3034,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3035,1,Headache,Headaches NEC,Headaches,Nerv,N
3035,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3035,3,Product substitution error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3036,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3036,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3036,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3036,4,Headache,Headaches NEC,Headaches,Nerv,N
3036,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3036,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3037,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3038,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3039,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3039,2,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
3039,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3040,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3041,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3041,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3042,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3043,1,Urine analysis abnormal,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
3044,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3044,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3045,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3046,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3046,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3046,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3046,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3046,5,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3046,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3047,1,Acute cardiac event,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
3047,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3047,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3047,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3047,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3048,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3049,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3049,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3050,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3051,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3051,2,Rubber sensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3051,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3052,1,Psychiatric disorder prophylaxis,Psychiatric therapies,Psychiatric therapeutic procedures,Surg,N
3052,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3053,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3054,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3054,2,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3054,3,Lip erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3054,4,Lip haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
3054,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3054,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3055,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
3055,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3055,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3056,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3056,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3056,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3056,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3057,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3057,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
3057,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3057,4,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3057,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3058,1,Coagulation test abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
3059,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
3059,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3059,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3060,1,Medication overuse headache,Headaches NEC,Headaches,Nerv,N
3061,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3062,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3062,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3062,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3062,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3063,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3064,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3065,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3066,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3066,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3067,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3067,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3068,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3069,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3070,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3070,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3070,3,Headache,Headaches NEC,Headaches,Nerv,N
3071,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3071,2,Application site photosensitivity reaction,Application site reactions,Administration site reactions,Genrl,N
3071,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
3072,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3072,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3072,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3072,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3072,5,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3072,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3073,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
3073,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3073,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3074,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3074,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3075,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3075,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3076,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3076,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3077,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3077,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3077,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3077,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3077,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3077,6,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3078,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
3079,1,Alcohol poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3079,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3080,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
3080,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3081,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
3081,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3082,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3083,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3083,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3083,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3083,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3083,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3083,6,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3084,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3084,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3084,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3084,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3085,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3086,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3086,2,Headache,Headaches NEC,Headaches,Nerv,N
3086,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3086,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3087,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3087,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3088,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3088,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3088,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
3088,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3088,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3088,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3088,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3088,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3089,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3089,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3089,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3089,4,Primary stabbing headache,Headaches NEC,Headaches,Nerv,N
3089,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3090,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3090,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3090,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3091,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3092,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3092,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3093,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3094,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3094,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3095,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3095,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3095,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3095,4,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3095,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3095,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3095,7,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3095,8,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3095,9,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3095,10,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3095,11,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3095,12,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3095,13,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
3095,14,Oral administration complication,Administration site reactions NEC,Administration site reactions,Genrl,N
3095,15,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3095,16,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3095,17,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3095,18,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3095,19,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3095,20,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3096,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3097,1,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3097,2,Brief psychotic disorder with marked stressors,Brief psychotic disorder,Schizophrenia and other psychotic disorders,Psych,N
3097,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
3097,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3097,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3097,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3097,7,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3098,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3099,1,Administration site irritation,Administration site reactions NEC,Administration site reactions,Genrl,N
3100,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3100,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3101,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3102,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3102,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
3102,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3102,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3102,5,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3102,6,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3102,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3103,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3103,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3104,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3104,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3104,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3105,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3105,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3106,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3107,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3108,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3108,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3109,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3109,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3110,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3110,2,Headache,Headaches NEC,Headaches,Nerv,N
3110,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3110,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3110,5,Migraine,Migraine headaches,Headaches,Nerv,N
3110,6,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
3110,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3110,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3111,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3112,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3112,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3112,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3113,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3113,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3113,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3113,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3113,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3114,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
3115,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3116,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3116,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3116,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3116,4,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3116,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3116,6,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3116,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3116,8,Drug withdrawal headache,Headaches NEC,Headaches,Nerv,N
3116,9,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3116,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3116,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3116,12,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3116,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3116,14,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3116,15,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3116,16,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3116,17,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3117,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3117,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
3117,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3118,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3119,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
3119,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
3120,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3120,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3120,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3121,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3122,1,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3122,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3122,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3123,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
3123,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
3124,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3124,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3124,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3124,4,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3124,5,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3124,6,Faeces soft,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
3124,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3124,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3124,9,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3125,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3126,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
3126,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3126,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3126,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3127,1,Vaccination site mass,Vaccination site reactions,Administration site reactions,Genrl,N
3128,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
3128,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3128,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
3128,4,Device leakage,Device issues NEC,Device issues,Prod,N
3129,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3130,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3131,1,Headache,Headaches NEC,Headaches,Nerv,N
3132,1,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3132,2,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
3132,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3133,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3133,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3134,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3135,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3135,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3136,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3136,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3136,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3136,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3137,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
3138,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3139,1,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3139,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3140,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3140,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3140,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3141,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3142,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3143,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3143,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
3143,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3143,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3144,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3144,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3145,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3145,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3145,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3146,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3147,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3148,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
3149,1,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3150,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3150,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3150,3,Headache,Headaches NEC,Headaches,Nerv,N
3151,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
3151,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
3152,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3153,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3153,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
3154,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3155,1,Headache,Headaches NEC,Headaches,Nerv,N
3156,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3156,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3157,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
3157,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3157,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3158,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3159,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
3159,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3159,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3159,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3159,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3160,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
3161,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3162,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3162,2,Dissociation,Dissociative states,Dissociative disorders,Psych,N
3162,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3163,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
3164,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3164,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3164,3,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3164,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3164,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3165,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3165,2,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
3165,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3166,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3166,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3167,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3167,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3167,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3168,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3169,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3169,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3170,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3171,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
3171,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3172,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3172,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3172,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3172,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3172,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3172,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3172,7,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3172,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3173,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3173,2,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3173,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3173,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3174,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3175,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
3175,2,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
3175,3,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3175,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3175,5,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
3176,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3176,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3176,3,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3176,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3176,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3177,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3177,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3177,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3177,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3177,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3178,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3179,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3180,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3181,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3181,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3182,1,Drug diversion,Criminal activity,Legal issues,SocCi,N
3182,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3183,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3183,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3183,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3183,4,Self-destructive behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3183,5,Social anxiety disorder,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
3184,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
3185,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3186,1,Bullous impetigo,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3186,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
3187,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3188,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3188,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
3188,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3189,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
3190,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3191,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3192,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3193,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3193,2,Irregular sleep wake rhythm disorder,Disturbances in sleep phase rhythm,Sleep disturbances (incl subtypes),Nerv,N
3193,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3194,1,Premature ejaculation,Orgasmic disorders and disturbances,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
3194,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3195,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3195,2,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
3195,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3195,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3196,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3196,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3196,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
3196,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
3196,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3197,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
3197,2,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
3197,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3198,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3199,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3200,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3200,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3200,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3200,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3201,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3202,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3202,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3203,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3203,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3204,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3204,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3205,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3205,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3206,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3207,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
3208,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
3209,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
3210,1,Drug use disorder,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3210,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3211,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3211,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3211,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
3211,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3211,5,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3212,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3213,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3213,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3214,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3214,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3215,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3215,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3216,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
3217,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3217,2,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
3217,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3217,4,Injection site laceration,Injection site reactions,Administration site reactions,Genrl,N
3217,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3217,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3217,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
3217,8,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3217,9,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3218,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3218,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3219,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3219,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3219,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3219,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3220,1,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3220,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3221,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3222,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3223,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3224,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3224,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3225,1,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
3225,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3225,3,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
3226,1,Headache,Headaches NEC,Headaches,Nerv,N
3227,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3227,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3227,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3227,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3228,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3229,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3230,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
3231,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3231,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3231,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3232,1,Application site plaque,Application site reactions,Administration site reactions,Genrl,N
3233,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3234,1,Application site plaque,Application site reactions,Administration site reactions,Genrl,N
3235,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3235,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3235,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3236,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3236,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3237,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3237,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3238,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3239,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3239,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3239,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3239,4,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
3239,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3239,6,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3239,7,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3239,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
3240,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3240,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3240,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3241,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3241,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3242,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3242,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3243,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3244,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3244,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3245,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3245,2,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3245,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3245,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3245,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3246,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3247,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3247,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3247,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
3247,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3247,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3247,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3247,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3247,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3247,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3248,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3248,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3248,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3249,1,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
3250,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3251,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
3252,1,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3253,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3253,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3254,1,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
3255,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3255,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3255,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
3255,4,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3255,5,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3255,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3255,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3255,8,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3256,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3257,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3258,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3258,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3259,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3259,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3259,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3259,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3259,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3259,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3259,7,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3259,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3260,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3261,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3261,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3261,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3261,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3261,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3261,6,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
3261,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3262,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3262,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3262,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3262,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3262,5,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
3262,6,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
3262,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3262,8,Dental discomfort,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
3262,9,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3262,10,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3262,11,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3262,12,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3262,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3262,14,Inappropriate schedule of product discontinuation,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3262,15,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3262,16,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
3262,17,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3262,18,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3262,19,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
3262,20,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
3262,21,Weight abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3263,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3263,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3263,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3263,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3264,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3265,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3266,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
3266,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3267,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3268,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3268,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3268,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3269,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3269,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3269,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3270,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3270,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3270,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3271,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3272,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3273,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3274,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3275,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3275,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3275,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3275,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3276,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3277,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3278,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3279,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3279,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3279,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3279,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3280,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3280,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3280,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3280,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3280,5,Joint instability,Joint related disorders NEC,Joint disorders,Musc,N
3280,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3281,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3282,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3283,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3284,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3284,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3284,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3284,4,Injection site scab,Injection site reactions,Administration site reactions,Genrl,N
3285,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3285,2,Migraine,Migraine headaches,Headaches,Nerv,N
3286,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3286,2,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
3286,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3286,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3286,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3287,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3288,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3289,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3290,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3290,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3290,3,Headache,Headaches NEC,Headaches,Nerv,N
3291,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
3291,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3291,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3291,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3291,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3292,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3293,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3294,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
3295,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
3295,2,Application site scab,Application site reactions,Administration site reactions,Genrl,N
3295,3,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3296,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3296,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3296,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3296,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
3296,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3296,6,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
3297,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3297,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3297,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3298,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3298,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3299,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3299,2,Headache,Headaches NEC,Headaches,Nerv,N
3299,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3300,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3300,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3300,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3301,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3301,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3301,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3301,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3301,5,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
3302,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3303,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3304,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3304,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3304,3,Headache,Headaches NEC,Headaches,Nerv,N
3305,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3306,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3306,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
3306,3,Death,Death and sudden death,Fatal outcomes,Genrl,N
3306,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3306,5,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3306,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3307,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3307,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3307,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3308,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3309,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3310,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3310,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3311,1,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
3311,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3311,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3311,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3312,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3312,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3313,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3314,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3315,1,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
3315,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3315,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3315,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3316,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
3317,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3317,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3318,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3318,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
3318,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3318,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3318,5,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
3318,6,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3318,7,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3318,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3318,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3319,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3319,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3320,1,Drug titration error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3320,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3320,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3320,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3321,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3321,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3322,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3322,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3322,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3322,4,Headache,Headaches NEC,Headaches,Nerv,N
3322,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3322,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3323,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3323,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3323,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3323,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3323,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3323,6,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3323,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3323,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3324,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3325,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3326,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3326,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3326,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3327,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3328,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3328,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3329,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
3330,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3330,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3330,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3331,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3331,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3332,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3332,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3332,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3333,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3334,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3334,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3335,1,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3336,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
3336,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3336,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3336,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3336,5,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
3336,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3336,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3337,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3337,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3337,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3337,4,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3338,1,Vaccination site pain,Vaccination site reactions,Administration site reactions,Genrl,N
3339,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3340,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3341,1,Blood creatine phosphokinase,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
3341,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3341,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3341,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
3341,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3341,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3341,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3342,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3342,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3342,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3342,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3343,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
3343,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3344,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
3344,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3344,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3345,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
3345,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3346,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
3346,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3346,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3347,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
3347,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3348,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
3348,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3349,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3350,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3351,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3351,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3352,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
3352,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3352,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3352,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
3352,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3352,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3353,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3353,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3353,3,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3353,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3353,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3354,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3354,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3354,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3355,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3355,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3355,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3355,4,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3355,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3356,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3357,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3357,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3357,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3358,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3358,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3358,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3358,4,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3358,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3358,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3359,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3360,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3360,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3360,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3361,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
3361,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3361,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3361,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3361,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3362,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3363,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3363,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3363,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3363,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3364,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3364,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3365,1,Headache,Headaches NEC,Headaches,Nerv,N
3365,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3366,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3366,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3366,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3366,4,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
3366,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3367,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3368,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3368,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3369,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3369,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3370,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3371,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3371,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3372,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3372,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3373,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3373,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3374,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3374,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3375,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3375,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3376,1,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
3376,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3377,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3378,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3379,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3379,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3380,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3380,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3380,3,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
3381,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3381,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3381,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3382,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3382,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3382,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3383,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3384,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
3385,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3386,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3387,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3388,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
3388,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3388,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3389,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3390,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3390,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3391,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3392,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3393,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3394,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3395,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3396,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
3396,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3396,3,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
3396,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3396,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3396,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3397,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3397,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3398,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3398,2,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3398,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3399,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
3400,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3400,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3401,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3401,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3402,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
3402,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3402,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3402,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
3402,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3402,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3403,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
3403,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3403,3,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
3404,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3405,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3405,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3406,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3407,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3408,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3408,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3408,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3409,1,Migraine,Migraine headaches,Headaches,Nerv,N
3410,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3410,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3410,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3410,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3411,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3412,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3412,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3412,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3413,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3413,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3413,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3413,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3413,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3414,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3415,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3416,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3416,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3417,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3418,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3419,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
3419,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3419,3,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3419,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3420,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3421,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3422,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
3422,2,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
3422,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3422,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3423,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
3423,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3423,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3423,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3423,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3424,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3425,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3425,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3425,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3426,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
3426,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3426,3,Headache,Headaches NEC,Headaches,Nerv,N
3426,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3426,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3426,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3426,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3427,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3427,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3428,1,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3428,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3429,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3429,2,Device leakage,Device issues NEC,Device issues,Prod,N
3429,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3429,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3429,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3430,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3431,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3432,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3432,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
3432,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3432,4,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3433,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3434,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3435,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
3436,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3436,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3437,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3438,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
3438,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3438,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3438,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
3438,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3438,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3438,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3439,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
3439,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3440,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3440,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3441,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3442,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3443,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3443,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3443,3,Self-destructive behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3443,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3444,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3444,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3445,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
3445,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3446,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3447,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3447,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3448,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3449,1,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3449,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3449,3,Obsessive thoughts,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
3449,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3450,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3450,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3450,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3451,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3451,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3451,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3451,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3452,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3453,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3454,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3455,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
3456,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3457,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3457,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3457,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3457,4,Wrong dose,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3458,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3458,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3458,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3459,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3460,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3461,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3461,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3462,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3463,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3464,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3464,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3465,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3466,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3466,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3466,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3466,4,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
3466,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3466,6,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3466,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3466,8,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3466,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3466,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3466,11,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
3467,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3467,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3467,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3467,4,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3467,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3468,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3469,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3470,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3471,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
3472,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3473,1,Headache,Headaches NEC,Headaches,Nerv,N
3474,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3475,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3475,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3476,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3476,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3477,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3477,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3478,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3479,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3480,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3480,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3480,3,Application site scab,Application site reactions,Administration site reactions,Genrl,N
3480,4,Wound abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
3481,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
3482,1,Asphyxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
3483,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3483,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
3484,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3484,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
3484,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3484,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3485,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3485,2,Enuresis,Psychiatric elimination disorders,Psychiatric disorders NEC,Psych,N
3485,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3485,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3485,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3486,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3486,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3487,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3488,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3488,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3489,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3490,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3491,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3492,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
3493,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3493,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3493,3,Intrusive thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
3493,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3493,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3494,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3495,1,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
3496,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3497,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3498,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3499,1,Headache,Headaches NEC,Headaches,Nerv,N
3499,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3499,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
3500,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3500,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3500,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3501,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3501,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
3501,3,Heart rate,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3502,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3502,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3502,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3502,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3502,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3502,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3502,7,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3502,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3502,9,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3502,10,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
3503,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
3503,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
3504,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3504,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3505,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3506,1,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
3507,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3508,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3508,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3508,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3508,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3508,5,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
3508,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3508,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3509,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3510,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3511,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3511,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3511,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3512,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3513,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3514,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3514,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3515,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3516,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3517,1,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
3518,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
3519,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3519,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3519,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
3520,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3520,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3521,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3522,1,Injection site hypoaesthesia,Injection site reactions,Administration site reactions,Genrl,N
3522,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
3523,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3523,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3524,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3524,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3524,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3525,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3526,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
3527,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3528,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3529,1,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
3530,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3530,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3530,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3530,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3531,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3531,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
3531,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3532,1,Hostility,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3533,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3533,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3534,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3535,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
3536,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
3537,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3538,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,Y
3538,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3538,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3539,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
3539,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3540,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
3541,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3541,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3541,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3542,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3542,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3543,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3544,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3545,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
3546,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3546,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3546,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3546,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3546,5,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
3546,6,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3546,7,Headache,Headaches NEC,Headaches,Nerv,N
3546,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3546,9,Urinoma,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
3547,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3547,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3548,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3548,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3549,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3550,1,Headache,Headaches NEC,Headaches,Nerv,N
3550,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3551,1,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
3552,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3553,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3554,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3555,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3555,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3556,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3557,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3558,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3558,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3558,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
3558,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
3559,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3560,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3560,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3561,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3562,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3563,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3563,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3563,3,Restless arm syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3563,4,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3564,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3565,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
3566,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
3567,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3568,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3568,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3568,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3568,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3568,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
3569,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3569,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3569,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3569,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3570,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3571,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3571,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3572,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3572,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3572,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3572,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3573,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3574,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3574,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3574,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3575,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3576,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3576,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3577,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3577,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3578,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
3579,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3580,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3581,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3581,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3582,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
3582,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3582,3,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3582,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3582,5,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3583,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3583,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
3584,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3584,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3585,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3585,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3586,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3586,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3586,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3586,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3587,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3588,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3589,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3589,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3590,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3590,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3590,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3591,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3591,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3591,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3591,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
3591,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3592,1,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3592,2,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3592,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3592,4,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
3592,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3593,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3594,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3595,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3595,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3596,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3596,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3597,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3597,2,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3597,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3597,4,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3597,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3597,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3597,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3598,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3598,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3598,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3598,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3599,1,Application site eczema,Application site reactions,Administration site reactions,Genrl,N
3599,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
3599,3,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3600,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3601,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
3601,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3601,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3601,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3602,1,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
3602,2,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3603,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3603,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3604,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3605,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3605,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3605,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3606,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3607,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3607,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3607,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3608,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3608,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3608,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3608,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3608,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3609,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3610,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3611,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3612,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3613,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3613,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3614,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3614,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3614,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3614,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3615,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3615,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3615,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
3616,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3616,2,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
3616,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3616,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3616,5,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3616,6,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3616,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3616,8,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3616,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3616,10,Slow speech,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
3617,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3618,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
3619,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3620,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3620,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3620,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3620,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3621,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3621,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3622,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3623,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3623,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3624,1,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3625,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3626,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3627,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
3627,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3627,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3628,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
3628,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3629,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3629,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3629,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3629,4,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
3630,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3631,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3632,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3632,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3632,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3632,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
3632,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3633,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3634,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3634,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3635,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3635,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3635,3,Nerve root injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
3635,4,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
3636,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
3636,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3636,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3636,4,Headache,Headaches NEC,Headaches,Nerv,N
3636,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3637,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3638,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
3638,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3639,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3639,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3640,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3640,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
3641,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3641,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3641,3,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
3641,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3641,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3642,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3642,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3643,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3643,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3644,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
3645,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3646,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3647,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3647,2,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3648,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3648,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
3648,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3649,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3650,1,Narcolepsy,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
3651,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3651,2,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
3651,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3651,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3652,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3652,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3653,1,Head titubation,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3654,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3655,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3655,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3656,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3657,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3657,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3658,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3659,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3660,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3660,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3661,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3661,2,Cortisol increased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
3661,3,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
3661,4,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
3661,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3661,6,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3661,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3661,8,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3661,9,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3661,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3662,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3663,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3664,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3664,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3665,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3666,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3666,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3667,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
3667,2,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3667,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3667,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3667,5,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3668,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3669,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3670,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3671,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3672,1,Headache,Headaches NEC,Headaches,Nerv,N
3672,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3672,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3673,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
3673,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3673,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3674,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3675,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3675,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3675,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3676,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3676,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3676,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3677,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3678,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3679,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3679,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3680,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
3681,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3681,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3681,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3681,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3681,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3681,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3682,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
3682,2,Motion sickness,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3683,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3684,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3684,2,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3685,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3686,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3686,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3686,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
3687,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3688,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3688,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3688,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3689,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3690,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3690,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3691,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3692,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3693,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3693,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3693,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
3694,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3695,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
3696,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3697,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3698,1,Burning sensation mucosal,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3699,1,Burning sensation mucosal,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3699,2,Circumoral swelling,Angioedemas,Angioedema and urticaria,Skin,N
3700,1,Ejaculation delayed,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
3701,1,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3701,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3701,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3702,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3703,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3703,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3703,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3704,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
3705,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3706,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3707,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3707,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3707,3,Lipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
3707,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3708,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3709,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3710,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
3710,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3710,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
3711,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3712,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3712,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3712,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3712,4,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3712,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3712,6,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3712,7,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
3712,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3712,9,Headache,Headaches NEC,Headaches,Nerv,N
3712,10,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3712,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3712,12,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3712,13,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3713,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3714,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3714,2,Headache,Headaches NEC,Headaches,Nerv,N
3714,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3714,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3715,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3716,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3717,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3718,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3719,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3720,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3721,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3722,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3723,1,Administration site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
3723,2,Administration site pruritus,Administration site reactions NEC,Administration site reactions,Genrl,N
3724,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
3725,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3725,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3726,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3726,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3727,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3728,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3729,1,Migraine,Migraine headaches,Headaches,Nerv,N
3730,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3730,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3731,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3731,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3731,3,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3732,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3733,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3733,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3734,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3734,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3735,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3735,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3736,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3736,2,Headache,Headaches NEC,Headaches,Nerv,N
3736,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3736,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3737,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3737,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3737,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3737,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3737,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3737,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3738,1,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3739,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3740,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3741,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3742,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3743,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3744,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3745,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
3746,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3747,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3748,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3749,1,Administration site irritation,Administration site reactions NEC,Administration site reactions,Genrl,N
3750,1,Anorgasmia,Orgasmic disorders and disturbances,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
3751,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
3752,1,Headache,Headaches NEC,Headaches,Nerv,N
3753,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3753,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3753,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3753,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3753,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3753,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3753,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3754,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3754,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3754,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3754,4,Headache,Headaches NEC,Headaches,Nerv,N
3754,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3754,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3755,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3756,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3756,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3757,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3757,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3757,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3757,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3757,5,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3758,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3758,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3759,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3759,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
3759,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3759,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3759,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3759,6,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3760,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
3761,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3761,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
3761,3,Dermatillomania,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
3761,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3762,1,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
3763,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3764,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3765,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3765,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3765,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3766,1,Urine output,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
3767,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3768,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3769,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3770,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3771,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
3772,1,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
3773,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3774,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3775,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3776,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3777,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3778,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3779,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3780,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3781,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3781,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3781,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3782,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3783,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3783,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
3783,3,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3783,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3783,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3784,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3785,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3786,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3786,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3787,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3788,1,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
3789,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3790,1,Vaccination site mass,Vaccination site reactions,Administration site reactions,Genrl,N
3791,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3791,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3791,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3791,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3792,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
3793,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3793,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3794,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
3794,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3795,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3796,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3797,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3798,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3799,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3799,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3800,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3801,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3801,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3801,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3801,4,Injection site scar,Injection site reactions,Administration site reactions,Genrl,N
3801,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3801,6,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
3802,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3802,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3802,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3803,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3804,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3805,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3806,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3807,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
3807,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3807,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3808,1,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3809,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
3809,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3809,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
3809,4,Application site nodule,Application site reactions,Administration site reactions,Genrl,N
3809,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3809,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3810,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3811,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
3811,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3811,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3811,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3811,5,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
3811,6,Eye colour change,"Iris and ciliary body structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
3811,7,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
3811,8,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3811,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3811,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3811,11,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3812,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3812,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3812,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3812,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3813,1,Administration site discomfort,Administration site reactions NEC,Administration site reactions,Genrl,N
3813,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3814,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3814,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3815,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3816,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3817,1,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3818,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3818,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3819,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3819,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3819,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3820,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3821,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3821,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3821,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3822,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3823,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3824,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3825,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3825,2,Menopause,Age related issues,Age related factors,SocCi,N
3826,1,Application site laceration,Application site reactions,Administration site reactions,Genrl,N
3826,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
3826,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3826,4,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3827,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3827,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3828,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3829,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3829,2,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
3829,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3829,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3830,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3831,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
3832,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3832,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3833,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3834,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3835,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3836,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3837,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3837,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3837,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3837,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3838,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3838,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3839,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3840,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
3840,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3840,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3840,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3840,5,Eye colour change,"Iris and ciliary body structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
3840,6,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
3841,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3842,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3842,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3842,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3842,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3842,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3842,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3843,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
3843,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3843,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3843,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3843,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3843,6,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3843,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3844,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3844,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3845,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3845,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3846,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3846,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3846,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3847,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3847,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3847,3,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3848,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3849,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3849,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3850,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
3851,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3851,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3852,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
3853,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3853,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3854,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
3855,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3855,2,Drug titration error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3856,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3857,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3858,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3858,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3859,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3859,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
3860,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
3861,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3861,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3861,3,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3861,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3861,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3861,6,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
